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Zusammenfassung 
 
 
Eine Strahlenexposition in utero stellt ein Risiko für den sich entwickelnden Embryo dar. 
Die Effekte von Niedrig-LET Strahlung auf verschiedene Embryonalstadien sind 
aufgrund von in vivo-Studien und epidemiologischen Daten weitestgehend bekannt. 
Daten für Effekte auf das früheste Stadium, die Präimplantationsphase, und speziell für 
Effekte von Hoch-LET Strahlung sind dagegen kaum verfügbar. Eine unbeabsichtigte 
Bestrahlung des frühen Embryos kann jedoch bei diagnostischen oder therapeutischen 
Anwendungen von ionisierender Strahlung oder bei Strahlenunfällen auftreten. Des 
Weiteren werden Protonen und Kohlenstoffionen vermehrt in der Strahlentherapie 
eingesetzt. Eine bessere Risikoabschätzung zur Wirkung von Hoch-LET Strahlung 
besonders auf den sehr frühen Embryo ist daher von Interesse. Um hierzu beizutragen, 
wurden in der vorliegenden Arbeit pluripotente embryonale Mausstammzellen 
verwendet, die mit dem frühen Embryonalstadium der Blastozyste vergleichbar sind. Im 
Anschluss an die Bestrahlung der Stammzellen mit Kohlenstoffionen (Hoch-LET 
Strahlen) und Röntgenstrahlen (Niedrig-LET Strahlen) wurden diese als Modell für die 
frühe Embryonalentwicklung differenziert. Das Auftreten von spontan kontrahierenden 
Kardiomyozyten wurde als Marker verwendet, um den Einfluss ionisierender Strahlung 
auf die Differenzierung zu erfassen. Neben weiteren Endpunkten wurden 
Zellinaktivierung, Zelltod und Genexpression untersucht. Die Experimente zeigten eine 
Verzögerung der kardialen Differenzierung nach Bestrahlung. Die Resultate weisen auf 
einen strahleninduzierten Zelltod als Hauptursache für die verzögerte Entwicklung hin. 
Kohlenstoffionen sind in diesem Zusammenhang effektiver als Röntgenstrahlen. 
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Abstract 
 
 
The in utero exposure to ionising radiation poses a risk for the radiosensitive developing 
embryo. Effects of low-LET radiation on different developmental stages of the embryo 
are relatively well known due to experimental studies and epidemiological data. Data for 
effects on the very early stage of the embryonic development, particularly the effects of 
high-LET radiation instead are rather limited. However, unanticipated exposures of the 
early embryo to ionising radiation may occur through diagnostic or therapeutic 
applications or through radiation accidents. Additionally, protons and carbon ions are 
increasingly used in radiotherapy. Thus, a risk estimation of high-LET exposure 
especially to the early embryo is of a certain importance. To address this topic, 
pluripotent mouse embryonic stem cells resembling the blastocyst stage were irradiated 
with high-LET carbon ions or low-LET x-rays and subsequently differentiated to mimic 
the early embryonic development. The occurrence of spontaneously contracting 
cardiomyocytes was used as a marker to asses the radiation effects on the differentiation. 
Among others, cell inactivation, cell death and gene expression were analysed. A delay in 
the cardiac differentiation after radiation exposure was found. The results point to 
radiation-induced cell killing as the main effector of the developmental delay. Carbon 
ions were found to be more effective than x-rays. 
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1. Introduction 
 
 
1.1 Motivation 
 
Humans are permanently exposed to ionising radiation from a natural background, 
coming from the earth itself or from space [Bundesamt fuer Strahlenschutz 2009, Hendry 
et al. 2009]. Ionising radiation comprises both high-LET radiation (such as α-particles or 
heavy ions) and low-LET radiation (for example γ- or x-rays). Additionally, a large 
number of people is exposed to ionising radiation coming from diagnostic and therapeutic 
applications [Bundesamt fuer Strahlenschutz 2001]. 
 
The health risk from an exposure to low-LET radiation is known rather well from 
experimental and epidemiological data. This is not the case for high-LET radiation, 
where only few data are available. However, risk estimations for high-LET radiation 
exposure are of a certain importance. Protons and carbon ions are used increasingly in 
modern cancer therapy due to their advantages compared to conventional radiotherapy 
[Weber and Kraft 2009, Durante and Loeffler 2010]. Carbon ions are even considered to 
be used in future for further therapeutic purposes, especially radiosurgery [Bert et al. 
2012]. Along with the application of high-LET radiation for medical purposes, 
unanticipated exposure to it, as can happen in accidents must be considered as well. The 
nuclear disaster of Fukushima in March 2011 is an example for an accidental exposure of 
a large number of people [Shigematsu et al. 2012]. Furthermore, since September 11th 
2001, nuclear terrorism is an up-to-date topic of public concern [Durante 2003, Williams 
and McBride 2011]. Large collectives might be exposed and inevitably will include 
pregnant women. 
 
Hence, there is a certain probability of an unanticipated exposure in the very early 
pregnancy, when in most cases it is still unknown to the expectant mother. The 
developing embryo is radiosensitive during the whole prenatal period in utero as 
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indicated by experimental data and epidemiology [ICRP 2003]. However, there are less 
data available for exposure during the pre-implantation period (i.e. the early phase of 
pregnancy). They are derived mostly from experiments and suggest lethality of the 
embryo as the dominating effect following low-LET exposure. Data for high-LET 
radiation instead are limited. 
 
These issues underpin the necessity of data on high-LET radiation for a better risk 
estimation during pregnancy. To contribute to this topic, in this work pluripotent mouse 
embryonic stem cells (mESC) were used as a model system as they resemble the 
embryonic development. In vitro differentiation then was done with cells exposed to low- 
or high-LET radiation. The radiation influence on pluripotency and differentiation was 
particularly assessed by investigating the early cardiac development, i.e. the formation of 
spontaneously contracting cardiomyocytes. 
 
1.2 Physical features of ionising radiation 
 
Radiation is referred to as ionising when the deposition of a sufficient amount of energy 
leads to ionisation, i.e. the ejection of an electron [Hall 2006]. These electrons are called 
secondary electrons [Scholz 2003]. The formation of secondary electrons, also called δ-
rays crucially contributes to the distribution of the deposited energy by ionisation of 
further atoms. This process is an important part for all kinds of ionising radiations [ICRU 
2011a]. Ionising radiation can be both, particle radiation or electromagnetic radiation 
(photons). X- and γ-rays are electromagnetic radiation whereas particle radiation 
comprises electrons, protons, α-particles, neutrons and heavy ions. Despite neutrons, all 
particle radiation is directly ionising, i.e. they disrupt the atomic structure producing 
damage by themselves. Photons and neutrons instead are indirectly ionising. Their energy 
is absorbed and produces charged particles that in turn produce the damage [Hall 2006, 
ICRU 2011b, Choppin et al. 2002]. 
 
The deposited energy (E) in a mass (m) of these processes is described as the absorbed 
dose (D) and has the unit Gray (Gy = J/kg) as shown in equation 1.1 [ICRU 2011b]. The 
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equivalent dose instead, measured in Sievert (Sv) is the absorbed dose multiplied by a 
quality factor [Durante and Cucinotta 2008]. 
 
][/][][ kgmJEGyD =
 (1.1) 
 
Concerning the dose deposition radiation can be differentiated in sparsely and densely 
ionising radiation. Photons and electrons are sparsely ionising radiations [Hall 2006]. A 
single photon introduces only a small amount of energy in a microscopic volume so that a 
certain energy amount is deposited by the contribution of several photons. That leads to a 
random spatial distribution of the incident photons and the resulting secondary electrons, 
resulting in a homogeneous dose distribution as seen in figure 1.1. Secondary electrons 
are produced as well by the interaction of densely ionising radiation with matter but the 
spatial distribution of the deposited energy differs completely from that of photons. The 
main part of the energy is deposited directly along the trajectory of the particle. The 
probability of ionisation events rapidly decreases with the distance from the core of the 
trajectory resulting in a track of a locally concentrated spatial energy deposition (see 
figure 1.1) [Scholz 2003]. 
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Figure 1.1 Dose distribution of photons and particles in a microscopic volume. Photons 
(Photonen) exposure results in homogenously distributed dose whereas particles (here lead ions, 
Pb-Ionen) deposit the dose non-homogenously and locally concentrated [Courtesy of M. Scholz]. 
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The energy deposition of radiation is characterised by the linear energy transfer (LET), 
which is the ratio of deposited energy (dE) per unit track length (ds) as shown in equation 
1.2 [Scholz 2003]: 
 
]/[/ µmkeVdsdELET =
 (1.2) 
 
Typically, densely ionising radiation consists of high LET-values and is therefore 
referred to as high-LET radiation. Sparsely ionising radiation instead has low LET-
values. The dose deposition of high-LET particles also depends on the fluence, i.e. the 
number of incident particles per area, which is given by the equation 1.3  
 
)/1(10602.1 9 ρ⋅⋅⋅⋅= − FLETD
 (1.3) 
 
where F is the fluence, i.e. number of particles per cm2 and ρ the density in g/cm3 
[Scholz 2003]. 
 
With a decreasing energy of the particle the ionisation density and thus the LET along the 
trajectory of the particle increase due to the higher probability of interaction with the 
matter (see figure 1.2). With an increasing depth in a tissue the velocity of the ion is 
reduced while energy deposition increases until its maximum range. At that point most of 
the ion’s energy is deposited. That maximum is referred to as the Bragg-peak 
[Scholz 2003]. 
 
The depth dose profile of particles therefore is referred to as inverted when compared to 
photons (see figure 1.2). Cancer therapy with ions takes advantage of that feature. Mostly 
carbon ions and protons are used due to their particularly advantageous depth dose 
profiles. Deep-seated tumours can thus be treated with a high dose while the ambient 
healthy tissue is spared. 
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Figure 1.2 Depth dose profiles of carbon ions versus photons [from Scholz 2003]. 
 
By changing the initial energies of the ions, their range can be varied and the whole 
tumour can be irradiated using the so called spread out Bragg-peaks (SOBP) or extended 
Bragg-peaks (see figure 1.3). The deposited dose in the tumour is homogenously 
distributed due to the superimposition of the single Bragg-curves [Weber and Kraft 
2009]. 
 
 
Figure 1.3 Spread out Bragg-Peak of carbon ions [from Scholz 2003]. 
 
1.3 Biological effects of ionising radiation 
 
The exposure of the human body to ionising radiation can lead to cancer [Shah et al. 
2012]. Radiation-induced mutations in the DNA are discussed as a reason for cancer 
Introduction 
 6 
[Goodhead 2009]. Experimental work has indeed proven a central role for the DNA in the 
radiation response [Munro 1970]. DNA is considered the main target for the radiation 
response, however, non-targeted/bystander effects are reported leading to damage in cells 
that are not directly traversed by radiation [Hei et al. 2011]. 
 
Ionising radiation can damage DNA in two ways. If the photon or the particle interacts 
with the DNA molecule it causes ionisations that result in breaks of the DNA-strands. 
This is a direct effect. In contrast, the indirect effect is based on the radiolysis of water, 
i.e. the formation of highly reactive hydroxyl radicals (OH-radicals) that subsequently 
damage DNA molecules in the environment [Hall 2006]. The resulting types of DNA 
damage are shown in figure 1.4. 
 
 
Figure 1.4 Types of DNA damages induced by ionising radiation [from Scholz 2003]. 
 
Among these damages the double strand breaks (DSBs) are considered the most critical 
events that lead to lethal lesions. Single strand breaks (SSBs) instead are less critical as 
they can be repaired readily using the opposite strand as template [Hall 2006]. To 
encounter the damage eukaryotes have evolved the so called DNA Damage 
Response (DDR), a complex repair mechanism pathway. It includes both the recognition 
of DNA damage and the subsequent signalling leading to different repair mechanisms, 
among them single-strand break repair (SSBR), non-homologous end joining (NHEJ) and 
homologous recombination (HR) that are particularly important for the repair of ionising 
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radiation-induced damages [Ciccia and Elledge 2010]. For embryonic stem cells (ESC), 
HR appears to be the predominant pathway as it conservatively repairs DNA damage 
using the sequence of the sister chromatid. A non-mutagenic DNA repair is pivotal for 
stem cells that would pass mutations to all cells they give rise to in an organism [Serrano 
et al. 2011]. 
 
A cell containing DNA damage undergoes cell cycle arrest in order to gain time to 
activate the repair mechanisms and to prevent the transmission of damaged DNA to 
daughter cells. Therefore, a molecular mechanism called DNA-damage checkpoints 
targets directly the major cell-cycle control machinery (checkpoint kinases) and a cell-
cycle arrest is either triggered in G1, intra-S or G2 phase, depending on when the damage 
occurs. Cells thereafter may repair the damage and re-enter the cell cycle (checkpoint 
recovery). Cells with improperly repaired damage can experience a permanent cell cycle 
arrest subsequently resulting in senescence or cell death [Medema and Macurek 2012]. 
ESC were shown to inefficiently activate the checkpoints leading to an increased cell 
death rate and thus maintaining a pristine cell population [Hong and Stambrook 2004, 
Desmarais et al. 2012]. 
 
Several kinds of cell death can occur following damage, among them necrosis, apoptosis 
and autophagy. The chosen mechanism depends on the damage the cells experience 
[Elmore 2007]. Necrotic cell death includes cytoplasmic swelling, rupture of the plasma 
membrane and a subsequent release of cellular material in the surroundings. Therefore, it 
is accompanied by inflammation, an adverse effect for the surrounding tissue. Autophagy 
and apoptosis instead are controlled ways of cell death that do not involve inflammation. 
Morphological features of cells undergoing apoptosis are chromatin aggregation, 
condensation (pyknosis) and fragmentation (karyorrhexis) of cell nuclei and cytoplasm 
developing the so called apoptotic bodies. These criteria were used in the current work to 
distinguish apoptotic cells (see chapter 2.6). Through phagocytic recognition and uptake 
they subsequently get removed from a tissue [Kerr et al. 1972, Elmore 2007]. Especially 
apoptosis is of a certain relevance for radiation induced cell death [Verheij and Bartelink 
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2000], however, it plays important roles also in other biological processes such as 
embryonic development [Fuchs and Steller 2011]. 
 
Apoptosis is mediated via different complex signalling pathways that all result in the so 
called execution pathway. Caspases (a group of cysteine proteases), that are activated by 
the different signalling pathways play a major role in it. Starting from activated initiator 
caspases, that amplify the protease cascade, the result is the activation of effector 
caspases, such as caspase-3 (see chapter 2.6) that in turn activate cytoplasmic 
endonucleases and other proteases, that lead to the classical features of apoptosis as 
described above [Roos and Kaina 2006, Elmore 2007]. 
 
Despite the elimination of damaged cells via apoptosis or senescence, misrepair of DNA 
damage and subsequent chromosomal rearrangements can occur. Several types of 
chromosomal aberrations are lethal to the cell. Other types of aberrations instead are 
consistent with cell viability and hence can be passed to the progeny. The occurrence of 
these rearrangements is frequently involved in neoplasia and carcinogenesis [Hlatky et al. 
2002, Hall 2006]. A transduction of chromosomal aberrations to the progeny of zygotes 
and mESC exposed to low-LET radiation is reported [Weissenborn und Streffer 1988, 
Rebuzzini et al. 2012]. In contrast to low-LET radiation, high-LET radiation leads to 
more complex lesions, for example clustered DSBs, due to the close vicinity of ionisation 
events. The repair of complex lesions is difficult and thus leads to cell death in most 
cases. But the residual complex damage of high-LET radiation in surviving cells is of 
particular concern for carcinogenesis [Maser and DePinho 2002, Cucinotta and Durante 
2006]. Along with chromosomal damage, gene expression alterations after exposure to 
ionising radiation have been reported and are depending on the LET [Ding et al. 2005, 
Durante and Cucinotta 2008]. 
 
The mentioned differences between high- and low-LET radiation in inducing the 
damages are mainly due to their different dose distribution, leading to differences in their 
effectiveness, which is estimated by the so called Relative Biological 
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Effectiveness (RBE). Normally 200 kV or 250 kV photon radiation is used as a reference 
to judge the RBE for an ion according to the equation 1.4: 
 
)(/ IsoeffectDDRBE ionphoton=  (1.4) 
 
where D are the absorbed doses of the different radiations. Besides the dose, the RBE 
further depends on physical factors, like the energy and therefore the LET of particles, 
the particle type and several biological factors, such as cell type, cell cycle stage and the 
used endpoint [Goodhead 1999, Weyrather et al. 1999, Scholz 2003, Durante and 
Loeffler 2010]. 
 
1.4 Early embryonic development 
 
Differentiation of embryonic stem cells (ESC) in vitro as performed in the present work 
is a useful tool to study the early embryonic development, especially the early cardiac 
development. The embryonic development of an organism is a highly complex process. 
Therefore this chapter gives a brief overview on the early mammalian development with 
a focus on the heart development. Embryonic development starts with fertilization of the 
oocyte in the oviduct. An early step in mammalian development, about one day after the 
fertilization is the cleavage. 
 
 
Figure 1.5 Early development in the pre-implantation mouse embryo [from Oron and 
Ivanova 2012]. 
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A mouse zygote (the fertilized oocyte), in contrast to frog or fish zygotes, does not yet 
have any polarity determined by maternal factors. Thus, in the first stages of cleavage 
(until 8-cell stage) the blastula cells retain the potential to form all cellular lineages, i.e. 
they are totipotent [Wobus and Boheler 2005, Oron and Ivanova 2012]. The first cleavage 
of the zygote is a normal meridional divison resulting in two blastomeres (2-cell stage, 
see figure 1.5). The second cleavage in mammalians instead is particular as it is a 
rotational cleavage, meaning one of the blastomeres does not divide meridionally but 
equatorially [Andreuccetti et al. 2010]. The third cleavage finally results in the 8-cell 
stage. Zygote genome activation (ZGA) also takes place in the early stages of cleavage 
[Oron and Ivanova 2012]. Once having reached the 8-cell stage, the loose arrangement in 
which the blastomeres exist turns into a compact structure. This process, referred to as 
compaction is triggered by an increased expression of cell adhesion proteins such as E-
cadherin that strengthen the cell-cell contacts and thus the compact arrangement of the 
blastomeres [Gilbert 2006, Takaoka and Hamada 2012].  
 
The cells of the 8-cell stage further divide forming the 16-cell morula, in which they 
become polarized being distinct into outward- (apical) and inward-facing (basolateral) 
regions. This polarization is a crucial prerequisite for blastocyst lineage differentiation, as 
the outer cells now will contribute to the trophectoderm (TE) lineage, whereas the inner 
cells will form the inner cell mass (ICM). While the TE represents the first tissue 
progenitor to be differentiated, the ICM remains pluripotent (see chapter 1.5.1) [Gilbert 
2006, Oron and Ivanova 2012]. 
 
The pluripotency in the ICM is maintained by transcription factor complexes, mainly 
involving Oct (Octamer binding transcription factor)-3/4, Nanog and Sox2 (SRY-box 2), 
that regulate the activity of downsteam genes [Tam and Loebel 2007]. For further details 
concerning signalling in maintaining pluripotency see chapter 1.5.1. By this time (about 
E4.0) the early mouse blastocyst reaches the uterus and for implantation needs to hatch 
from the zona pellucida, the extracellular matrix covering of the zygote avoiding ectopic 
pregnancy. Following hatching, the blastocyst can interact with the endometrium (uterine 
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epithelium) and implantation can take place [Gilbert 2006, Rossant and Tam 2009, Oron 
and Ivanova 2012]. 
 
In the following stage of post-implantation development the ICM separates into the 
primitive endoderm (PE) and the epiblast (EPI, also termed primitive ectoderm) as shown 
in figure 1.6 [Zwaka and Thomson 2005, Oron and Ivanova 2012]. 
 
 
 
Figure 1.6 Lineage separation and germ layer differentiation in the mouse development [from 
Keller 2005]. 
 
The epiblast is the starting point of another determining step in development called 
gastrulation, in which the three primary germ layers (ectoderm, mesoderm and endoderm) 
will arise. The formation of the primitive streak is the morphological onset of the 
gastrulation. The nascent mesoderm arising in the further development can be subdivided 
into four different regions that develop in the next time after the gastrulation, i.e. the 
chordamesoderm, the paraxial mesoderm (also called somitic mesoderm), the 
intermediate mesoderm and the lateral plate mesoderm (see figure 1.7) [Gilbert 2006, 
Tam and Loebel 2007, Nowotschin and Hadjantonakis 2011]. 
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Figure 1.7 Mesodermal lineage separation [from Gilbert 2006]. 
 
The lateral plate mesoderm will eventually form the circulatory system, i.e. blood vessels 
and particularly the heart [Gilbert 2006]. The circulatory system represents the first 
functional unit in a developing embryo including the heart being the first functional 
organ. The lateral plate mesoderm subdivides in turn again into different lines 
(splanchnic, somatic and extraembryonic), from which the anterior splanchnic mesoderm 
will give rise to the heart (see figure 1.7). The splanchnic lineages from which the heart 
originates are therefore also termed cardiogenic mesoderm and are located in two clusters 
lateral from the rostral notochord (see figure 1.8). By this time, the cardiogenic 
mesoderm already expresses cardiac specific genes like Nkx2.5 and Gata4 [Zaffran and 
Frasch 2002, Gittenberger-de Groot et al. 2005, Gilbert 2006]. 
 
Both fields of the bilateral cardiac mesoderm eventually converge contemporary into the 
midline of the embryo and the former bilateral heart structure will fuse to a single tube 
(see figure 1.8). The resulting tubular heart subsequently starts beating around the 
embryonic day 8.5 (E8.5) [Zaffran and Frasch 2002, Gilbert 2006, Wagner and Siddiqui 
2007]. The morphogenesis continues via looping and subsequently, the heart chamber 
formation takes place giving the heart the final shape as seen in the adult organism, 
including left and right ventricles and atriums etc. [Bruneau 2002, Gilbert 2006]. 
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Figure 1.8 Mouse heart development from cardiac mesoderm to the mature heart [from 
Bruneau 2002]. 
 
Eventually, the heart has developed out of the cardiac progenitors that form all kind of 
endocardial and myocardial cells present in a heart, i.e. atrial and ventricular musculature, 
cushion cells of the valves, Purkinje conduction fibres and the endothelial lining of the 
heart [Gilbert 2006]. 
 
1.5 Embryonic stem cells as a model system 
 
1.5.1 Features of embryonic stem cells 
 
Research on embryonic stem cells (ESC) and their cultivation in vitro brought up major 
advances in biology and experimental medicine. Unlimited self-renewal and multilineage 
differentiation are classical features of ESC. Therefore, ESC are a suitable model to study 
early mammalian development and a putative tool for replacement therapy [Keller 2005]. 
Embryonic stem cell research started in the early 1970s using embryonal carcinoma 
cells (ECC). ECC lines are generated by isolation from teratocarcinomas and share the 
capacity of self-renewal and mulitlineage differentiation with other ESC [Yu and 
Thomson 2008]. A further step in the in vitro use of ESC was the establishment in culture 
of mESC [Evans and Kaufman 1981, Martin 1981]. In the late 1990s, the establishment 
of human embryonic stem cells (hESC) in vitro followed [Thomson et al. 1998]. Two 
major limitations for the use of hESC in research however are ethical concerns and legal 
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restrictions [Bundesministerium der Justiz - StZG 2002, Leist et al. 2008]. The use of 
mESC therefore provides an alternative tool, at least for studies of developmental issues. 
 
Nowadays, mESC cell lines are available commercially. Originally they are derived from 
the inner cell mass (ICM) of pre-implantation embryos (blastocysts) of the mouse (see 
figure 1.6). The stage of pre-implantation in which they are commonly isolated is around 
the embryonic day 3.5. The blastocysts, after isolation from the murine uterus are 
cultured in vitro on mouse embryonic fibroblasts (MEF). Subsequently, through 
enzymatic dissociation and expansion mESC are generated out of the cells from the ICM 
and are separated from the throphoblast cells [Evans and Kaufman 1981, Wobus 
and Boheler 2005]. 
 
Cells derived from that stage are considered pluripotent, i.e. they retain the potential to 
differentiate into cells of all three primary germ layers (namely endoderm, mesoderm and 
ectoderm) and the primordial germ cells (PGC), the founder cells of male and female 
gametes (see figure 1.9). Subsequently, they can further differentiate into all cells of the 
mouse organism [Wobus and Boheler 2005]. 
 
 
Figure 1.9 Stem cell hierarchy and differentiation [from Wobus and Boheler 2005]. 
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Their pluripotent stage can be used in vitro for differentiation into cells of all three germ 
layers as well. However, to retain the pluripotency in culture, mESC need special 
conditions. A coculture of mESC on a feeder layer of MEF is sufficient to provide all 
factors maintaining their pluripotency [Keller 2005]. It was found that leukemia 
inhibitory factor (LIF), a feeder-cell-derived molecule, is one of the pivotal factors 
maintaining pluripotency. Additionally, it was demonstrated that with recombinant LIF in 
the presence of a proper fetal calf serum (FCS) the maintenance of pluripotent cells was 
possible without a feeder layer [Williams et al. 1988, Stewart et al. 1992]. 
 
LIF maintains pluripotency of mESC mainly by activating different signalling pathways 
(see figure 1.10). Prior to all, LIF binds to the LIF receptor (LIFR) which then triggers 
several signalling pathways. The pathways comprise the JAK/STAT (Janus kinase/signal 
transducer and activator of transcription 3), the PI3K (phosphoinositide 3-kinase) and the 
SFK (Src family kinases) pathway. Additionally, the canonical Wnt pathway and bone 
morphogenetic protein 4 (BMP4) signalling via the Smad pathway are involved. The 
Ras/RAF/MEK/ERK cascade, also triggered by LIF would result in differentiation 
instead, showing a double function of LIF, but it is inhibited by the other pathways [Ying 
et al. 2003, Annerén 2008, Pera and Tam 2010, Hirai et al. 2011]. 
 
Figure 1.10 Pluripotency maintained by LIF, BMP and Wnt signalling [from Annerén 2008]. 
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Eventually, these pathways trigger the expression of transcription factors, which together 
with epigenetic modifiers, chromatin remodelers and miRNAs form a regulatory system 
to maintain pluripotency of stem cells. Oct-3/4, Sox2, Nanog and cMyc are among the 
key players of transcription factors. They co-occupy at promoter regions and thus repress 
genes involved in early lineage differentiation and activate genes responsible for self-
renewal. Furthermore, they positively regulate each others expression to maintain the 
system keeping mESC in a pluripotent state [Chambers et al. 2003, Masui et al. 2007, 
Pera and Tam 2010, Smith and Dalton 2011]. 
 
1.5.2 In vitro differentiation of mouse embryonic stem cells 
 
Mouse embryonic stem cells are able to differentiate in vitro spontaneously into a variety 
cell types [Doetschman et al. 1985]. Under appropriate conditions mESC differentiation 
starting from ICM cells allows the generation of cells of the three germ layers plus their 
derivatives (see figure 1.9). Conditions necessary to start the spontaneous differentiation 
are the aggregation of mESC to form embryoid bodies (EBs) using for example the 
hanging drop method in the absence of LIF or feeder layer cells providing it. Efficiency 
and direction in which differentiation is driven depends on the used serum [Keller 2005, 
Wobus and Boheler 2005]. 
 
In vitro differentiation of mESC by EBs can recapitulate in parts the embryonic 
development of mice. Figure 1.11 shows how EB differentiation resembles to the various 
developmental steps. Like maintenance of pluripotency and self-renewal, differentiation 
of mESC in vitro is mediated by a complex network of signalling, interplay of 
transcription factors and others, which is found as well in vivo [Niwa 2010]. 
 
The process of gastrulation, resulting in the three germ layers, can be recapitulated as 
well. The signal pathways of BMP, Wnt and activin/Nodal are core components inducing 
endodermal, ectodermal and mesodermal lineages during gastrulation-like processes and 
primitive streak-like cell populations were found in vitro. From the emerging mesoderm, 
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among others, hematopoietic, vascular and cardiac lineages can be generated in a defined 
temporal pattern [Murry and Keller 2008, Tanaka et al. 2011]. 
 
 
Figure 1.11 Differentiation of mESC in EBs compared to the in vivo development of a mouse 
embryo. Day 0 refers to the initiation of spontaneous differentiation, when hanging drops are 
done and LIF has been removed [from Keller 2005]. 
 
A temporal pattern of activation and inhibition of signalling and factors is typical for 
developmental processes and it can be recapitulated in vitro. However, a spatial 
expression pattern is needed in vivo as well for the shaping of the embryo. It has been 
shown that even spatial gene expression patterns and spatial self-organization take place 
in differentiating EBs in vitro. Thus, early EBs shortly after differentiation begin consist 
of an outer layer of cells resembling the primitive endoderm, while the inner cells 
resemble the primitive ectoderm forming the epiblast (see figure 1.11). Lateron, 
gastrulation-like processes, such as the formation of a primitive streak-like structure 
including cell migration, involution and epithelial-to-mesenchymal transition (EMT) 
were observed in EBs of mESC. These resulted in an anteroposterior polarity and a 
bilateral symmetry in the EB. Pivotal for mimicking also these processes is an 
implantation-like process, i.e. the attachment of EBs on the surface of a tissue culture 
plate after a few days. However, only early stages were found resembling the in vivo 
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situation, as the following organogenesis due to complexity exceeds the possibility of 
mimicking the development in an EB [ten Berge et al. 2008, Fuchs et al. 2011]. Another 
crucial feature of embryonic development is programmed cell death, especially apoptosis. 
It contributes to patterning and normal development of the organism [Fuchs and Steller 
2011]. Interestingly, apoptosis related to differentiation processes is also seen in EBs 
[Karbanová and Mokrý 2002]. 
 
Particularly the embryonic development of the heart can be studied by differentiation of 
mESC into cardiomyocytes. In fact, derivation of cardiomyocytes from mESC is the most 
successful event in directed lineage differentiation [van Laake et al. 2005] and has been 
investigated in the present study after exposure to x-rays and carbon ions. A variety of 
specialized cardiac cell types, for example atrial-like, ventricular-like and Purkinje-like 
cells can be derived in vitro [Boheler et al. 2002, Baharvand et al. 2006] and a 
spontaneous contraction activity of cardiomyocytes was shown in EBs [Doetschman et al. 
1985]. Several days after differentiation begins beating foci emerge in the EBs and their 
number might increase over the differentiation period. Their electrophysiological 
properties can be measured and are comparable with those of the in vivo situation. The 
beating activity can last up to several weeks. However, in vitro generated cardiomyocytes 
can be kept in culture beyond that [Boheler et al. 2002, Banach et al. 2003]. 
 
1.6 Embryonic stem cell test 
 
The in vitro differentiation of mESC into spontaneously contracting cardiomyocytes (see 
chapter 1.5.2) is also the base of the embryonic stem cell test (EST). The EST is a model 
to assess embryotoxictiy of drugs and other compounds in vitro, using mechanisms like 
cytotoxicity and differentiation [Seiler and Spielmann 2011]. In the present study, the 
basics of this assay were used to investigate the embryotoxic effect of ionising radiation. 
Embryotoxicity testing commonly is accompanied with the sacrifice of pregnant animals 
as a model, such as the rat limb bud micromass assay or the postimplantation rat whole 
embryo culture assay [Scholz et al. 1999]. The EST instead uses established cell lines and 
pregnant animals as a source for embryonic tissue are not needed to be sacrificed here 
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[Seiler and Spielmann 2011]. Its protocol has been validated in a study by the European 
Centre for the Validation of Alternative Methods (ECVAM) and published as a standard 
operating procedure for embryotoxicity testing [Balls 2002, Scholz and Spielmann 
INVITTOX no. 113 2002]. 
 
The EST uses two commercially available cell lines, namely the murine embryonic stem 
cell line ES-D3 and the murine fibroblast line Balb/c 3T3. For cytotoxicity testing of 
compounds, both lines are treated with chemicals before applying the 3-(4,5-
dimethylthiazol-2yl)-2,5-diphenyl tetrazolium bromide (MTT) test. To asses the 
influence of a compound on the differentiation, ES-D3 cells are differentiated into 
spontaneously contracting cardiomyocytes using the hanging drop method to create EBs 
(see figure 1.13, for a detailed description of the assay see Scholz and Spielmann 
INVITTOX no. 113 2002). The compound to be tested is applied over the whole 
differentiation period and the yield of spontaneously contracting EBs in controls is 
compared to the yield after treatment with different concentrations [Scholz et al. 1999, 
Seiler and Spielmann 2011]. 
 
 
Figure 1.13 Experimental scheme of the differentiation endpoint of the embryonic stem cell test 
[from Seiler and Spielmann 2011]. 
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2. Materials and methods 
 
 
2. 1 Pluripotent ES-D3 cells and culture conditions 
 
2.1.1 Mouse embryonic stem cell line ES-D3 
 
In this work the pluripotent mouse embryonic stem cell line ES-D3 [Doetschmann et al. 
1985] was used. These cells were derived from the inner cell mass of eight blastocysts of 
day 4 of embryonic development. The blastocysts were isolated from pregnant 129/Sv 
mice. ES-D3 cells were purchased from American Type Cell Culture (ATCC). Cells were 
purchased cryo-preserved and defined to be in passage 0, as no further details on the 
culture age were provided by ATCC. Cells were thawed and subsequently cultured as 
needed (see below). 
 
2.1.2 Gelatine-treatment of tissue culture flasks and dishes 
 
All tissue culture flasks used for ES-D3 cultivation and all 24-well tissue culture plates 
used for differentiation of EBs (see 2.2.1) were pre-treated with a 0.1% (w/v) gelatine 
solution. Gelatine granulate was dissolved in pre-warmed PBS-/- while stirring with a 
magnetic stirrer. Once gelatine was dissolved, the solution was sterilized by autoclaving 
and stored at 4°C. To treat the tissue culture flasks or dishes, sterile gelatine solution was 
filled inside to cover the whole surface (0.2 ml/cm2). The solution in the flask or dish was 
then incubated (37°C, 5% CO2 and 95% humidity) for at least 1h. Following the 
incubation the gelatine solution was removed and the flasks or dishes prepared as 
required. 
 
 
 
Materials and methods 
 21 
2.1.3 Culture conditions and cultivation 
 
ES-D3 cells were incubated at 37°C, 5% CO2 and 95% humidity. Due to their fast and 
colony-like growth they were passaged every second or third day to avoid confluence. 
For the passage, medium was removed from the tissue culture flask and cells were 
washed with phosphate buffered saline without calcium and magnesium (PBS-/-). 
Trypsin-Ethylenediaminetetraacetic solution (TE solution) was added (1 ml per 25 cm2) 
and incubated at room temperature to detach cells from the surface and to dissociate the 
colonies. The process was checked under the microscope and supported by smooth 
tapping. As soon as the cells were detached, the activity of the TE solution was stopped 
by adding complete medium (see appendix C.3). A single cell suspension was prepared 
by repeated pipetting. A sample of the cell suspension was diluted 1:10 in PBS-/- and 
counted with an electrical cell counter to determine the cell number. To completely 
remove the TE solution, cell suspension was centrifuged at 800 rounds per minute (rpm) 
for 8 minutes. The supernatant was poured off and cells were resuspended in complete 
medium to reach 1*106 cells/ml. For further cultivation, 1*106 cells were seeded in a 
prepared tissue culture flask (gelatine-treated, 6 ml complete medium, preconditioned in 
incubator for 30 minutes) of 25 cm2 (T25). LIF was added in a concentration of 
1000 U/ml medium to maintain the pluripotency of ES-D3 cultures (see chapter 1.5.1). 
This very scheme was applied on Mondays and Wednesdays. On Fridays, due to the 
additional day in culture, only 0.75*106 cells were seeded in a T25 tissue culture flask 
and 10 ml of complete medium with LIF to avoid nutritional limitations of the cultures. 
 
2.1.4 Heat inactivation of foetal calf serum 
 
The foetal calf serum (FCS) added to the cell culture medium was heat-inactivated 
before. A 500 ml bottle of FCS was defrosted and aliquots were done in 15 ml or 50 ml 
tubes. These tubes then were incubated at 56°C for 30 minutes in a water bath and 
immediately after chilled in an ice bath. Tubes with heat-inactivated FCS were stored at -
18°C until needed. 
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2.1.5 Cryopreservation and thawing 
 
For cryopreservation cells were trypsinized as described in 2.1.3, centrifuged and 
carefully resuspended in cryo medium (see appendix C.3) to reach a concentration of 
2.5*106 cells/ml. The cryo vials were then filled with 1.2 ml of cell suspension so that 
each contained 3*106 cells and were placed in a cell freezing container filled with 
isopropanol to ensure a freezing rate of 1°C/min while kept at -80°C. After one to three 
days cryo vials were moved to a liquid nitrogen container for long-term preservation. 
To thaw cells, a cryo vial was taken and the screw cap was slightly opened to allow 
degassing. Cells in the vial were then defrosted at 37°C in a water bath. Cell suspension 
was transferred in a 15 ml tube containing 9 ml pre-warmed complete medium and 
centrifuged at 800 rpm for 8 minutes. The supernatant was poured off and the pellet 
resuspended in 1 ml complete medium. This suspension was transferred in a prepared 
tissue culture flask (T25, gelatine-treated, 6 ml complete medium including LIF, 
preconditioned in incubator for 30 minutes). and incubated under normal culture 
conditions (see 2.1.3). One day later, the medium was replaced by 7 ml fresh complete 
medium including LIF. Cells were passaged the following day as described in 2.1.3. 
 
2.2 Differentiation of ES-D3 cells to spontaneously contracting 
cardiomyocytes 
 
2.2.1 Differentiation protocol 
 
For the differentiation into spontaneously contracting cardiomyocytes, only ES-D3 cells 
up to a passage number of 20 were used in analogy to the embryonic stem cell test 
[Scholz and Spielmann INVITTOX no. 113 2002]. A scheme of the procedure is shown 
in figure 2.1. To initiate the spontaneous differentiation, LIF was removed from the 
culture medium and the hanging drop method was applied [e.g. Seiler and Spielmann 
2011]. The start of the differentiation process was defined as day 0. Briefly, cells were 
trypsinized (see 2.1.3), resuspended in complete medium to adjust a cell titre of 
3.75*104 cells/ml and transferred to a sterile multipipette tray. Regularly, the multipipette 
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tray was smoothly shaken to avoid cells to sink down and thereby generating a titre 
gradient. From that cell suspension 40 drops (20 µl each) were put inside the lid of a 
bacterial Petri dish using a multichannel pipette. Thus, each drop contained about 750 
cells. The Petri dish was filled with 5 ml sterile PBS-/- to prevent evaporation of the small 
volumes. After seeding 40 drops, the lids were flipped around carefully without moving 
the drop’s positions and put on the dish. The dishes containing were then incubated 
(37°C, 5% CO2 and 95% humidity) for 3 days. Thus, due to gravity the cells gathered in 
the tip of the drop forming EBs. On day 3 of differentiation, the lids of the dishes were 
carefully flipped around and the EBs of three lids were transferred to Petri dish 
containing 15 ml complete medium and cultured for two more days in suspension to 
allow further growth. On day 5 of differentiation, when visible by the naked eye, single 
EBs were picked and transferred in a cavity of gelatine-treated 24-well tissue culture 
plates (one per well). For the transfer, pipette tips were used, where the end was cut off to 
decrease shear forces. In the tissue culture plates EBs attached, flattened and grew 
extending into the periphery. While differentiating EBs gave rise to several cell types, 
among them spontaneously contracting cardiomyocytes. 
 
Day 0
Day 3
Day 3
Day 5
 
Figure 2.1 Scheme of ES-D3 differentiation. The formation of the EBs is achieved by aggregation 
in the hanging drops (days 0 to 3, upper left picture). Subsequently the spherical EBs are grown 
in suspension culture (days 3 to 5, lower left picture) and plated in a 24-well tissue culture 
plate (day 5). 
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2.2.2 Determination of the fraction of beating embryoid bodies 
 
Spontaneously beating cardiomyocytes can be easily detected about ten days after 
initiation of the differentiation (five days after transfer in 24-well tissue culture plates) 
due to their visible contractions. The number of beating EBs showing one or more 
beating areas was determined by light microscopy (10x magnification). At least 48 EBs 
per dose and time-point were examined. For high doses with an expected low occurrence 
of beating cardiomyocytes up to 96 EBs were examined. Analysis was done in regular 
intervals between day 10 and day 30 of differentiation. The cumulative fraction of 
beating EBs, i.e. EBs were counted as positive if they had been beating at least once, was 
determined over the time-course. 
 
2.2.3 Serum test to obtain high numbers of spontaneously 
contracting cardiomyocytes 
 
The protocol described in 2.2.1 was applied to test three different sera for their potential 
to induce the differentiation into high numbers of spontaneously contracting 
cardiomyocytes and thus in a high fraction of beating EBs. The 3 sera used were A, B 
and C (see appendix C.4). Before differentiation protocols with the mentioned sera were 
applied, pluripotent ES-D3 cultures were kept for at least three passages before initiating 
the differentiation in the serum of choice to allow adaption to changed conditions. Then, 
cells were differentiated and the efficiency of the tested serum was calculated by 
determining the fraction of contracting EBs as described in 2.2.2. For each serum at least 
one differentiation was performed including at least two 24-well tissue culture plates (48 
EBs). 
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2.3 Radiation experiments 
 
2.3.1 Sample preparation 
 
Pluripotent ES-D3 cultures were irradiated either one or two days after seeding (see 
2.3.4) in gelatine-treated 12.5 cm2 tissue culture flasks (T12.5). The cell number seeded 
was 0.5*106 per T12.5, if cells were irradiated one day after seeding. For irradiations two 
days after seeding, 0.4*106 cells were seeded to ensure that cells were in the exponential 
phase at the time of exposure. In both cases, cells were kept in 3.5 ml complete medium 
including LIF. Irradiations were done both with x-rays or accelerated carbon ions at room 
temperature (details are given in chapters 2.3.2 and 2.3.3). Controls were sham-irradiated. 
 
2.3.2 Exposure to x-rays 
 
Exposure of ES-D3 cells to x-rays was performed with an Isovolt DS1 x-ray tube of 
250 kV accelerator voltage and 16 mA cathode current. While running, the wolfram 
anode of the tube emitted x-rays. In front of the exit window of the x-rays, a filter 
consisting of 7 mm beryllium, 1 mm aluminium and 1 mm copper was mounted to absorb 
long-wave x-rays to harden the spectrum. The applied dose was measured using a 
dosimeter (SN4). The distance between the exit window and the sample was about 20 cm 
which resulted in a dose-rate of 2 Gy/min. The T12.5 flasks containing the cells were 
positioned horizontally below the exit window and exposed to doses of 1 to 10 Gy of x-
rays. Following irradiation the samples were transferred to the laboratory for further 
processing. 
 
2.3.3 Exposure to carbon ions 
 
The exposure of ES-D3 cells to high-energy carbon ions was performed at the SIS18 
(Schwerionensynchrotron) at GSI in Darmstadt. Shortly before irradiation, the flasks 
were entirely filled with complete medium and placed in vertical positions on a belt 
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conveyer in front of the beam exit window. The bottom of the flask with the cells on it 
faced that exit window. A laser-system was used for positioning. Cells were irradiated 
with carbon ions (25 mm-extended Bragg peak, energy-range: 106-147 MeV/u with a 
mean LET of 75 keV/µm at the sample position) using the intensity controlled raster 
scanning technique [Haberer et al. 1993] and a 30 mm poly(methyl methacrylate) bole. 
Doses ranged from 0.5 to 3 Gy of carbon ions. Irradiations of a set of several doses in 
average took about 1h. Following exposure the samples were transferred to the laboratory 
for further processing as required. 
 
2.4 Experimental processing scheme following radiation 
exposure 
 
Two main experimental schemes for processing were applied after irradiation of ES-D3 
that are referred to as 0h experiments (0h) and 72h experiments (72h). 
 
2.4.1 Experiments at 0h 
 
For the 0h experiments, cells were processed directly after exposure to assess the direct 
damage induced by radiation. They were harvested as described in 2.1.3. The cell 
suspension then was used for different experiments as required. 
 
2.4.2 Experiments at 72h 
 
For the 72h experiments, to asses delayed damage or effects of radiation cells were 
processed one day after exposure. After exposure to x-rays the tissue culture flasks were 
transported to the laboratory and placed in an incubator. In contrast, following exposure 
to carbon ions, where flaks were entirely filled, medium was removed completely to 
restore the proper LIF concentration. Then, 3.5 ml complete medium including LIF were 
added. Tissue culture flaks were then put in the incubator for further 24h. Cells were 
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harvested as described in 2.1.3 one day after exposure and the suspension was used for 
different experiments as required. 
 
2.5 Differentiation of ES-D3 and analysis of beating embryoid 
bodies after radiation exposure 
 
2.5.1 Experiments at 0h 
 
ES-D3 cells were processed immediately after exposure as described in 2.4.1 and 
differentiation was performed subsequently (2.2.1). Analysis of beating EBs and 
calculation of their cumulative fractions was done as described in 2.2.2. The scheme is 
shown in figure 2.2. 
 
 
Figure 2.2 Scheme for differentiation and analysis of beating embryoid bodies after exposure in 
0h experiments. The yellow flash and the red circle indicate the time of radiation exposure. 
Initiation of differentiation is defined as day 0. Beforehand, cells were grown in culture 
conditions for the maintenance of pluripotency (black arrow, days -3 to 0). After that, 
differentiation via hanging drops, EB formation and plating of EBs took place (red arrow, day 0 
and following). Microscopic analysis of beating EBs started at day 10. 
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2.5.2 Experiments at 72h 
 
ES-D3 cells were processed after exposure as described in 2.4.2. At 24h post-irradiation 
cells were passaged. Differentiation was done 72h after radiation exposure as described 
(2.2.1). Analysis of beating EBs and calculation of their cumulative fractions was done as 
described in 2.2.2. The scheme is shown in figure 2.3. 
 
 
Figure 2.3 Scheme for differentiation and analysis of beating embryoid bodies after exposure in 
72h experiments. The yellow flash and the red circle indicate the time of radiation exposure. The 
green arrow indicates the passage which is performed one day after exposure. Initiation of 
differentiation is defined as day 0. Beforehand, cells were grown in culture conditions for the 
maintenance of pluripotency (black arrow, days -3 to 0). After that, differentiation via hanging 
drops, EB formation and plating of EBs took place (red arrow, day 0 and following). Microscopic 
analysis of beating EBs started at day 10. 
 
2.6 Measurements of cell death after radiation exposure 
 
Apoptosis was measured in two systems, i.e. in pluripotent cultures reseeded directly or 
one day after exposure and in differentiating EBs for 0h and 72h experiments. 
 
2.6.1 Reseeded pluripotent cultures 
 
Cell death after exposure was measured in pluripotent ES-D3 cultures. For analysis, cells 
were reseeded in T12.5 tissue culture flasks immediately after exposure (0h experiments, 
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2.4.1) or one day after exposure (72h experiments, 2.4.2). For each sample and control, 
three T12.5 were seeded with each 0.5*106 cells. Cells were harvested for analysis one, 
two and three days after. 
Cells were harvested and counted as described above (see 2.1.3). The PBS-/- used to wash 
the cells and the cell suspension were transferred in the 15 ml tube and centrifuged for 10 
minutes at 1200 rpm. Then, the supernatant was poured off and the pellet resuspended in 
1 ml PBS-/-. To fix cells, 333 µl of 3.7% paraformaldehyde (PFA) solution was added and 
samples were stored at 4°C until further processing. Cell nuclei were stained by adding 
116 µl of 10 µg/ml Hoechst 33 342 solution (final concentration of 0.8 µg/ml). The cells 
were incubated in the staining solution for at least 15 minutes at room temperature. Then, 
a few micro litres were dropped on a glass slide (76 x 26 mm), covered with a cover slip 
(24 x 46 mm) and analysed under a fluorescence microscope using a DAPI filter and a 
40x magnification. The fraction of apoptotic nuclei was determined based on 
morphological criteria, i.e. mainly condensation and fragmentation of cell nuclei. For 
each dose and time point at least 1000 cells were evaluated. 
 
2.6.2 Differentiating embryoid bodies 
 
Cell death was also measured in EBs derived from exposed cells. For that, samples were 
taken on day 1, 3 and 5 of differentiation corresponding to days 1, 3 and 5 after exposure 
(0h experiments) and to days 4, 6 and 8 after exposure (72h experiments), respectively.  
To obtain a sufficient number of cells, on day 1 and 3 of differentiation, 3 dish lids 
containing hanging drops were flushed and EBs were collected in 10 ml PBS-/-. On day 5 
of differentiation, one dish of EBs in suspension culture was used. By rotating the dish, 
EBs were collected in the centre and taken with a pipette in 1 ml medium. The EBs were 
transferred into a 15 ml tube containing 10 ml of PBS-/-. In both cases, the tubes with the 
EBs were centrifuged for 8 minutes at 800 rpm. The supernatant was removed and 1 ml 
of TE solution was added. EBs in the TE solution were incubated at 37°C in a water bath 
for 5 minutes. Afterwards, EBs were resuspended by repeated strong pipetting to enhance 
the dissociation process. The dissociation was controlled under a light microscope. Once, 
single cells predominated, 3 ml of complete medium were added to inhibit the activity of 
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the trypsin in the TE solution.  Then, cells were centrifuged at 800 rpm for 8 minutes and 
the supernatant was poured off. The pellet was resuspended in 1 ml of PBS-/- and 333 µl 
of 3.7% PFA solution was added to fix the cells. Samples were stored for 1h at room 
temperature. Thereafter, cell nuclei were stained and analysed as described in 2.6.1. 
 
2.6.3 Caspase-3 activity assay 
 
Additionally to the morphological analysis of apoptotic cells, caspase-3 activity was 
measured in a few samples of a 0h experiment by means of the FITC Active Caspase-3 
Apoptosis Kit. Cells were reseeded after exposure as described in 2.6.1 and harvested 
one, two and three days after exposure (see 2.1.3). The PBS-/- used to wash the cells and 
the cell suspension were transferred in the 15 ml tube and cells were processed according 
to the manufacturer’s protocol. Generally, 1*106 were transfered to a separate 15 ml tube 
and centrifuged at 300 g for 5 minutes. The supernatant was poured off and cells were 
washed twice with ice-cold PBS-/- and centrifuged each at 300 g for 5 minutes. 
Subsequently, cells were resuspended in 500 µl Cytofix/Cytoperm Fixation and 
Permeabilization Solution and incubated on ice for 20 minutes. Then, they were washed 
twice with Perm/Wash Buffer (1x diluted) and centrifuged each at 500 g for 5 minutes. 
The cell pellet was resuspended in an antibody staining solution (per sample 100 µl 
Perm/Wash Buffer and 20 µl FITC Rabbit Anti- Active Caspase-3) and incubated for 30 
minutes at room temperature in the dark. Subsequently, cells were centrifuged at 500 g 
for 5 minutes and washed in 1 ml of Perm/Wash Buffer followed by another 
centrifugation step. The pellet was then resuspended in 500 µl Perm/Wash Buffer 
containing 1 µg/ml DAPI to allow simultaneously the detection of cell nuclei in the flow 
cytometer. 
As a first gating step the cell cycle distribution measured with DAPI stained cells was 
used. A following gating step was performed on the FSC/SSC plot that displays the size 
distribution of the cell population. These gating steps excluded putative debris and 
clumps. For the remaining population the FITC intensity was analysed. For that, the 
control of each time point was analysed first and its FITC-intensity was set to a 
background containing 5% FITC positive cells, i.e. active caspase-3 positive cells. The 
Materials and methods 
 31 
very same gating parameter was then applied for all measurements and results were 
normalized to control. 
 
2.7 Size measurements of embryoid bodies after radiation 
exposure 
 
To gain information on the growth of EBs after radiation exposure their diameter was 
measured on day 5 of differentiation, right after plating in the cavities of the 24-well 
tissue culture plates. Measurements were performed by a scale in the ocular of a light 
microscope. 
 
2.8 Clonogenic survival assay 
 
The determination of the clonogenic survival after irradiation is a central assay in 
radiation biology. The clonogenic survival describes the capability of a single cell to 
grow to a colony of at least 50 cells within a certain time [Franken et al. 2006]. To reach 
a sufficient statistical value, a total of about 100 colonies per sample were aimed at and 
each sample was plated three times. In the case of ES-D3, a defined cell number was 
plated in T25. After seven days of incubation (37°C, 5% CO2 and 95% humidity), cells 
were fixed and stained with 3x Loeffler’s Methyleneblue solution. Colonies with more 
than 50 cells were counted as survivors. The plating efficiency (PE) of control cells (i.e. 
the ratio between seeded cells and formed colonies) is an important parameter for this 
assay. The PE was calculated for each experiment and set to 1. The surviving fractions of 
the exposed samples were then calculated as the ratio between counted colonies and 
seeded cells and normalised to the control value. 
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2.9 Isolation and immunocytochemical staining of 
cardiomyocytes 
 
Cells samples isolated from EBs were stained with for the protein cardiac troponin I to 
proof the formation of cardiomyocytes. On day 21 of differentiation, EBs containing 
contracting areas were scraped with a cell scraper and transferred in a 15 ml tube with 
5 ml PBS-/-. The sample was then centrifuged at 800 rpm for 2 minutes and the pellet was 
transferred in a reaction tube. EBs were washed three times with PBS-/- and centrifuged 
shortly to spin them down. The PBS-/- was removed and 500 µl of TE solution were 
added. Samples were incubated for 6 minutes at 37°C in a water bath to dissociate the 
EBs. Then, the suspension was resuspended several times with a pipette to remove the 
remaining clumps. Afterwards, 1 ml of complete medium was added to inactivate the TE 
solution. The cell suspension was transferred to gelatine-treated chamber slides with each 
two chambers (400 µl/chamber). Additionally, 1.6 ml of complete medium per chamber 
were added and slides were shaken carefully to distribute the cells. Samples were then 
incubated (37°C, 5% CO2 and 95% humidity) for 20h to 24h before further processing. 
To fix and stain the cells, medium was completely removed, cells were washed with 
PBS -/- and afterwards 1 ml of a 2% PFA solution was added. Samples were incubated for 
15 minutes at room temperature. Then, the PFA solution was removed, cells were washed 
with PBS-/- and 1 ml of 0.5% Triton solution was added. The samples were incubated for 
10 minutes at room temperature. After removing the solution, they were washed twice 
with PBS-/- for 3 minutes. This was followed by blocking the samples for 20 minutes with 
0.4% BSA solution. Meanwhile, primary antibody solution was prepared by diluting the 
antibody stock (rabbit, cardiac troponin I) to 2.5 µg/ml in 0.4% BSA solution. After 
removal of the BSA solution, 300 µl of primary antibody solution were added per 
chamber. Two chambers were used as control, i.e. one was only filled with BSA as 
autofluorescence control and one with the secondary antibody to assess unspecific 
immunostaining. Incubation was done for 2h at room temperature in a humidified 
chamber. Subsequently, the primary antibody solution was removed and samples washed 
three times with PBS-/- for 5 minutes. Following the washing steps, in each chamber 300 
µl of secondary antibody solution (sheep, anti-rabbit, TexasRed-labeled, 5 µg/ml in 0.4% 
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BSA solution) were added and incubated at room temperature for 45 minutes in a 
humidified chamber. Afterwards, samples were washed with PBS-/- for 5 minutes. 
Staining of the cell nuclei was performed by adding 0.1 µg/ml DAPI solution. After 15 
minutes samples were washed with PBS-/- and subsequently with deionised water (each 5 
minutes). Samples were dried at room temperature and the walls of the chamber slides 
were removed. A few drops of VectaShield Antifade were added on the slides and they 
were covered with cover slips (24 x 46 mm). Analysis was done with a fluorescence 
microscope using DAPI and TexasRed filters and 40x and 100x magnifications. Images 
were taken with a monochrome CCD camera and analysed using the ISIS software. 
 
2.10 Alkaline phosphatase staining 
 
A high activity of alkaline phosphatase is typical marker for the pluripotency of 
embryonic stem cells [Wobus et al. 1984]. Therefore, ES-D3 cells were tested for 
alkaline phosphatase activity in regular intervals to proof whether they were still 
pluripotent. The assays were performed with the Alkaline Phosphatase Kit (Sigma 
Aldrich) according to the manufacturer's protocol with minor changes. All steps were 
performed at room temperature. Cells for the assay were grown in T25. Per T25 the 
following reaction volume was prepared before the start of the staining procedure. 
Staining solution was produced by mixing 133 µl Sodium Nitrite Solution and 133 µl 
FRV-Alkaline Solution and incubating it for 2 minutes. After that 6 ml of deionised water 
and 133 µl Naphthol-AS-BI were added. The fixative solution was prepared by mixing 
2.5 ml Citrate Solution, 6.5 ml Acetone and 0.8 ml of 37% formaldehyde. 
Following the preparations, medium was removed and cells were washed carefully with 
PBS-/-. The fixative solution was added and incubated for 30 seconds. Cells were then 
washed for 45 seconds with deionised water. Right after, the staining solution was added 
and incubated for 15 minutes avoiding direct exposure to a light source. Cells were 
washed with tap water and the sample was air-dried. The staining was evaluated using a 
light microscope. 
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2.11 Western blot analysis 
 
Western blot analysis was performed along the differentiation period of ES-D3 to proof 
the development of cardiomyocytes in EBs. Therefore, samples were taken at different 
time points both from EBs and from the pluripotent culture, i.e. day 0 of differentiation. 
At day 0 a total of 6*106 cells were collected from the cell suspension prepared to 
produce hanging drops (see 2.2.1). At days 10, 15, 21 and 30 of differentiation 48, 46, 24 
and 13 EBs, respectively, were collected by scrapping. Collected samples were washed 
twice with PBS-/- and disrupted in RIPA buffer. The samples were incubated on ice for 15 
minutes, subjected to mechanical disruption by ultrasound sonication for 10 periods of 15 
seconds on medium intensity, with pauses of 15 seconds in between. The cell lysate was 
cleared by centrifugation at 13000 rpm for 10 minutes at 4ºC. The protein content in the 
supernatant was quantified by the Bradford method [Bradford 1976 from thesis Winter]. 
Of each sample, 100 µg of protein including molecular weight ladder were loaded into 
12% SDS-PAGE gels (see appendix) and subjected to electrophoresis (120V, 90 minutes) 
using SDS runnig buffer (see appendix). The electrophoresed proteins were transferred 
into PVDF membranes using 1x Transfer buffer (see appendix) at a voltage of 100V for 
35 minutes. Following the transfer, membranes containing the protein bands were 
blocked for 1h at room temperature in TBST (see appendix) containing 5% milk with 
gentle agiation. The membranes were blotted with antibodies specific for cardiac troponin 
I and alpha tubulin (both 1 µg/ml in TBST, overnight, 4°C) and horseradish peroxidase 
(HRP)-linked anti-rabbit secondary antibody (1:5000 in TBST, 1h, room temperature). 
The immunoreactive bands were visualized by chemiluminescence using ECL-Plus and 
Amersham HyperflimTM ECL film. The films were developed in a developer. 
 
2.12 Cell proliferation in embryoid bodies 
 
To measure proliferation of cells in the EBs, the Click-iT EdU Flow Cytometry Assay Kit 
and the Click-iT EdU Imaging Kit were used according to the manufacturer’s protocol 
with minor changes. EdU (5-ethynyl-2’-deoxyuridine) is an analogue to the nucleoside 
thymidine and is incorporated into the DNA during synthesis. For the EdU-pulse 
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labelling, 10 µM of EdU were added to control EBs and to EBs from the progeny of a 
3 Gy x-rays exposed sample on day 5 of differentiation in suspension culture. The EBs 
were incubated for 2h under normal conditions. Sample collection and single cell 
suspension was obtained from EBs as described in 2.6.2 and the cell suspensions of the 
control and the exposed sample were separated in two to subject them to the different 
analyses. 
Firstly, for flow cytometry analysis (Click-iT EdU Flow Cytometry Assay Kit), 
1*106 cells of the suspension were centrifuged at 975 rpm for 3 minutes. The cells were 
washed in 3 ml 1% BSA solution in PBS-/- and centrifuged. The supernatant was poured 
off, the pellet resuspended in the residual volume, 200 µl of Click-iT fixative were added 
and incubated light-protected at room temperature for 15 minutes. Cells were 
subsequently washed in 3 ml 1% BSA solution in PBS-/- and centrifuged. The pellet was 
resuspended in 200 µl 1x Click-iT saponin-based permeabilization and wash reagent and 
incubated as mentioned above for 15 minutes. Meanwhile, for each sample 0.5 ml of the 
Click-iT reaction cocktail using the Alexa Fluor 488 azide dye were prepared as 
described in the manufacturer’s protocol, added to the samples and incubated light-
protected at room temperature for 30 minutes. Then, cells were washed with 3 ml 1x 
Click-iT saponin-based permeabilization and wash reagent and centrifuged. The pellet 
was resuspended in 500 µl 1x Click-iT saponin-based permeabilization and wash reagent 
including 1 µg/ml DAPI and incubated in the same conditions for another 15 minutes. 
The samples were analysed by flow cytometry. Several gating steps were performed as 
described in 2.6.3 and the fluorescence intensity of Alexa Fluor 488 (FITC channel) was 
analysed first in the control and its level of EdU-positive cells, i.e. cycling cells was set 
arbitrarily to 10% to allow comparison with the exposed sample. Then, the fluorescence 
intensitiy of the exposed samples was normalized to the control. 
Secondly, for the microscopic analysis (Click-iT EdU Imaging Kit), the cell suspensions 
from both samples were fixed and dropped on glass slides (76 x 26 mm) as commonly 
done for chromosome spreads [Ritter et al. 1996]. Staining was done as described for 
flow cytometry analysis adjusting the conditions and the volumes for a sample fixed on a 
glass slide. As dye, Alexa Fluor 594 azide was used here instead. Following the staining 
procedure, both control and exposed sample were analysed with a fluorescence 
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microscope using a TexasRed filter. At least 1000 cells were analysed in each sample and 
the percentage of EdU-positive cells was determined. 
 
2.13 Gene expression 
 
For the gene expression studies the quantitative reverse transcription polymerase chain 
reaction (qRT-PCR) method was used. The method requires isolation of RNA from 
samples and the subsequent reverse transcription reaction to yield cDNA that is then 
subjected to quantitative analysis of gene expression. 
On day 0 (undifferentiated cells), samples were harvested from non-exposed ES-D3 
cultures as described in 2.1.3. For all other time points, both controls and EBs derived 
from cells exposed to 3 Gy of carbon ions or x-rays were harvested. On day 4, each two 
dishes of EBs in suspension cultures were collected and on day 6, each 36 randomly 
chosen EBs were scraped and harvested. For the following time points (day 10, 15, 21, 25 
and 30), with increasing differentiation time less EBs were harvested (12, 10, 7, 6 and 4 
EBs) to avoid interference of the RNA isolation efficiency due to excessive sample 
material. The selection for harvesting beating or non-beating EBs reflected the fraction of 
beating EBs counted for the respective day. All samples were washed twice with ice-cold 
PBS-/- and transferred in a 1.5 ml reaction tube. 
For RNA extraction, the MasterPure RNA Purification Kit was used according to the 
manufacturer’s protocol with minor changes. The supernatant was removed carefully 
from the washed and centrifuged samples. EB samples from day 10 of differentiation on 
were additionally pre-treated with a pestle on ice during the subsequent cell lysis step. 
The following RNA isolation procedure was performed according to the manufacturer’s 
protocol. The purified RNA pellets of the samples in the end of the procedure were 
resuspended in 20 µl TE Buffer including 1 µl of RiboGuard RNase Inhibitor and stored 
at -80°C until they were used for RNA concentration measurement and cDNA synthesis. 
RNA concentration was measured by diluting the sample 1:50 in ultrapure water in a 
photometer. For the reverse transcription reaction, the High Capacity RNA-to-cDNA Kit 
was used to synthesise cDNA. Briefly, 2 µl of each cDNA sample were reversed 
transcribed as recommended in the manufacturer’s protocol. 
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For qRT-PCR analysis the reagent Fast SYBR Green Master Mix was applied and each 
2 µl of cDNA of the samples were subjected to the reactions. Quantification was done by 
using standard curves for each analysed gene and each measure point was performed in 
triplets. For details about the primers (see appendix C.7). The reactions were performed 
in a thermocycler with integrated fluorescence reading unit applying the following 
program: initial denaturation (95°C, 20 seconds), 40 cycles of denaturation (95°C, 3 
seconds) followed each by primer annealing and extension (60°C, 30 seconds), 
denaturation (95°C, 15 seconds) and final elongation (60°C, 60 seconds). As a final step, 
a melting curve was performed by increasing the temperature stepwise (0.3°C/min) to 
95°C. The relative quantity of the analysed genes was each normalised to the relative 
quantity of the geometric mean of two house keeping genes (Gapdh and Eef2). 
Furthermore, for pluripotency-associated marker genes (Sox2, Nanog and Oct-3/4) the 
relative quantity of expression was normalised to an undifferentiated control sample. For 
cardiac marker genes (Gata4, cAct, cTropT2, Myh7, and Hcn4, see chapter 4.5.5), the 
relative quantity of expression was normalised to a control sample of day 10 of 
differentiation. 
 
2.14 Mathematical modelling 
 
To justify the hypothesis that the effects concerning the beating fraction of EBs after 
radiation exposure are mainly due to the cell number, a mathematical model containing a 
simple cell number-based feature was developed (see equation 2.2) 
 
ντ )))/()/exp(()/(( 001)( DDtNkbeat eNP −−−=  (2.2) 
 
where Pbeat(N) is the probability that a spontaneous beating activity occurs, k the initial 
number of cells, N0 the threshold necessary for beating activity, time t the day of 
differentiation, τ the growth rate, D the dose, D0 the dose necessary to obtain a survival 
rate of 1/e and ν a parameter determining the slope. 
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The model reflects the contribution to the overall cell number due to cell killing 
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and counteracting cell growth 
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Combining those in a probabilistic approach for a spontaneous contraction in an EB 
results in 
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which is equation 2.2. To find the needed parameters, a non-linear fitting to the mean 
value of all control data was done using the OriginPro 8G software. The used control data 
were derived from the four figures displaying the developmental kinetics of 
spontaneously contracting cardiomyocytes as shown in 3.3.2. The initial cell number k 
used for calculations was 750 and the population doubling time td to calculate τ was 
assumed as for pluripotent ES-D3 with 17h. For that purpose, the above mentioned 
equation without the radiation influence term (D/D0) was applied. The parameters were 
found to be N0 = 97 and ν = 0.041. Subsequently, using the calculated parameters, the 
measured data were modelled using equation 2.2 for exposed data sets. For controls, 
equation 2.2 was used without the radiation influence term (D/D0). 
 
2.15 Error analysis and significance tests 
 
For the error calculation the standard error of the mean (SEM), the standard deviation 
(SD), the Poisson distribution or the Bernoulli distribution were used as indicated. For 
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significance testing, the Fisher’s exact test or the t test were used to compare 
experimental results. 
 
Results 
 40 
3. Results 
 
 
The main purpose of this work was to get deeper insight on how radiation exposure might 
affect the early embryonic development. Therefore, pluripotent ES-D3 cell cultures 
(resembling the early blastocyst stage) and their differentiation ability (resembling the 
early embryonic development) were examined after irradiation. Differentiation into 
beating cardiomyocytes was the central endpoint of the studies. Carbon ions as used for 
cancer therapy and x-rays as a reference radiation were applied. In a first approach, stem 
cells were differentiated immediately after radiation exposure (0h experiments). Possible 
delayed effects were assessed by maintaining them after exposure for three days in 
pluripotent culture conditions before differentiation (72h experiments). 
For pluripotent cultures clonogenic cell death was assessed by performing survival curves 
(3.2.1). Apoptosis after exposure was mainly measured by counting DAPI stained 
apoptotic cell nuclei. Additionally, measuring points of apoptosis were confirmed by a 
caspase-3 activity assay (3.2.2). The radiation influence on the differentiation potential 
was monitored analysing the occurrence of spontaneously contracting cardiomyocytes 
(3.3.1 and 3.3.2). The existence of cardiomyocytes in the EBs was proven by means of 
Western Blot technique and immunocytochemistry (3.1.3). For assessing radiation 
damage in differentiating cells, EBs were dissociated and screened for apoptotic nuclei 
(3.3.6). Furthermore, the cell growth in the EBs used for the assays was assessed by 
measuring the diameter of EBs (3.3.3) and their proliferation (3.3.4). To verify the 
influence of the cell number and cell killing on the final outcome different initial cell 
numbers were seeded to produce EBs (3.3.5) and a mathematical model was applied 
(3.3.7). Complementary, gene expression studies of pluripotency-related and cardiac 
markers were carried out to screen putative radiation-induced changes (3.3.8). 
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3.1 Preparatory experiments  
 
The pluripotency stage of the used ES-D3 cultures was examined. Additionally, sera were 
tested for the efficiency of differentiation into cardiomyocytes and in contracting EBs the 
presence of cardiomyocytes was proven. 
 
3.1.1 Pluripotency of ES-D3 
 
ES-D3 cells were stained in regular intervals for the alkaline phosphatase activity to 
investigate whether cells used for experiments were still pluripotent. Cultures were 
examined at an early passage number (one passage after thawing), i.e. passage number 6 
and at a later passage number (11 to 15), i.e. when radiation experiments were performed.  
Staining was analysed with light microscopy. The analysis showed that all colonies in the 
passages expressed the alkaline phosphatase activity. Figure 3.1 demonstrates the result 
of such a staining. The ES-D3 colonies displayed the red/purple colour indicating the 
pluripotent state. Few cells surrounding them do not. Those cells were typically present 
in the cultures and did not show alkaline phosphatase activity, indicating a progenitor or 
differentiated state. However, the majority of cells remained positive for alkaline 
phosphatase activity. 
 
250 µm
 
Figure 3.1 ES-D3 cells stained for alkaline phosphatase activity (red/purple stain) in passage 
number 6. The ES-D3 colonies display the red/purple stain. 
 
Results 
 42 
Further tests to analyse the cells' potency state were performed in the context of that 
work. Flow cytometry was used to analyse the immunocytochemically stained 
plruripotency markers Sox2 and Oct-3/4. These data showed that both markers were 
expressed in the cultures indicating the pluripotent stage of the ES-D3 cultures. Results 
are shown elsewhere [Luft et al. 2013a, in press]. 
 
3.1.2 Serum testing to obtain a high efficiency of differentiation into 
spontaneously contracting cardiomyocytes 
 
Before the performance of the radiation experiments, three different sera (A, B and C, for 
details see appendix C.4) were tested for their potential to obtain a high fraction of 
beating EBs. A sufficient number of contracting EBs is important to obtain statistically 
relevant data. For the present study, a benchmark of at least 60% in controls was chosen 
for the experiments. Interestingly, all three tested sera induced a similar and sufficient 
proportion of beating EBs, i.e. 80% ± 10% on day 10 of differentiation [Helm et al. 
2011]. Therefore, the serum commonly used in the laboratory (serum A) was chosen for 
all further experiments and to maintain the ES-D3 cultures. 
 
3.1.3 Expression of cardiac troponin I in beating embryoid bodies 
 
The formation of cardiomyocytes can be monitored under a light microscope as they 
contract spontaneously. To further prove the existence of cardiomyocytes, spontaneously 
beating EBs were tested for expression of cardiac-specific markers. The analyses 
described below were performed at a few selected time points in some differentiation 
experiments to verify the existence of cardiomyocytes. 
First, eight beating EBs at day 10 of differentiation were dissociated and the 
cardiomyocytes were immunocytochemically stained by fluorescence-labelling with 
antibodies against cardiac troponin I as shown in figure 3.2. The fraction of 
cardiomyocytes positive for cardiac troponin I among all cells counted was always 
below 5%. 
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10 µm
 
Figure 3.2 Differentiated cardiomyocyte from a contracting embryoid body. The EB was 
dissociated, cells were reseeded and cardiac troponin I as a marker for cardiomyocytes detected 
by immunocytochemistry and fluorescence-labelling under a fluorescence microscope 
(100x magnification). 
 
Additionally, analysis of protein expression of cardiac troponin I by Western Blot 
technique was performed for EBs along the differentiation period (figure 3.3). On days 
10, 15, 21 and 30 the protein was detected regularly. As shown in the figure, cardiac 
troponin I could not be detected on day 0 in the pluripotent cultures, although the double 
amount of proteins was loaded on the gel to detect also small traces. This is due to the 
fact that differentiation had not yet begun and the sample consists of pluripotent 
embryonic stem cells that did not express structural proteins of cardiomyocytes. Those, 
however, were present from day 10 on. 
 
Figure 3.3 Expression of the cardiomyocyte marker cardiac troponin I (cTROP-I) along the 
differentiation period of the embryoid bodies (0 to 30 days). Contracting EBs were taken as 
samples, lysed and analyzed by Western Blot technique using chemiluminscence. Tubulin was 
used as a loading control. The gel was loaded with 50 µg (days 10, 15, 21 and 30) and 10 µg 
(day 0) of protein sample. 
Days after differentiation initiation 
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3.2 Effects of radiation on pluripotent ES-D3 cultures 
 
3.2.1 Cell survival 
 
Survival curves up to doses of 5 Gy are shown in figure 3.4. Cells were plated 
immediately after exposure (0h) or three days after exposure including a passage in 
between (72h). In both cases, carbon ions are more effective in cell inactivation than x-
rays. The RBE of carbon ions is about 3 for 0h as well as for 72h. The cell survival for 
both radiation qualities is at 72h by a factor of 2 higher than at 0h comparing iso-effective 
doses. 
 
 
Figure 3.4 Survival curves for carbon ions and x-rays plated immediately after irradiation (0h) 
and 3 days after exposure (72h). Data show mean values of different independent experiments 
and the error bars express the standard deviation. For curve fittings a linear fit was used. 
 
3.2.2 Cell death 
 
Cell death in proliferating pluripotent cultures reseeded directly after irradiation was 
measured at one, two and three days after exposure. Additionally, to estimate a putative 
influence of radiation-induced cell death on the differentiations performed three days 
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after exposure (72h experiments), apoptosis on day 2, 3 and 4 was measured from cells 
reseeded on day 1 after irradiation. 
To evaluate the relevance of effects, firstly the mean cell death rate of all control samples 
from all experiments (n=10) was calculated. Values for days 1 and 2 after reseeding were 
used. The mean value was found to be 2.3% (± 0.3%, standard error of the mean). On day 
3 after reseeding the rate of cell death was elevated in all experiments to around 9%. This 
is most likely due to starvation. Therefore, values measured at day 3 after reseeding were 
not pooled with the control background. Moreover, the influence of starvation on the cell 
death on this day exacerbates the distinction of radiation-induced cell death. 
 
In figure 3.5 the number of dead cells in percent is shown one, two and three days after 
exposure to 0.5 and 3 Gy of carbon ions. On day 1 after irradiation only the 3 Gy exposed 
sample shows a significant increase in apoptosis (approximately 17%, p < 0.05, t test) 
compared to the control (around 2%). On the second day an increase was measured also 
for 0.5 Gy, while the sample exposed to 3 Gy is still significantly (p < 0.05, t test) 
elevated compared to both other samples. The control remains on its level from before. 
On the third day, all samples are on a higher apoptosis level when compared to before. 
Starvation of the cultures might be the reason here, however, the 3 Gy exposed sample 
still is higher than the other two. 
 
Figure 3.6 shows the cell death rates one, two and three days after exposure to different 
doses of x-rays. Apoptosis on day 1 after exposure to 6 and 10 Gy is higher than the 
control level in (about 7 and 18% respectively, p < 0.01, Fisher’s exact test); 1 and 3 Gy 
do not differ from the control, which is about 3%. At two days after exposure, the control 
remains at the same level (approximately 4%). The irradiated samples instead have a 
higher level of cell death when compared to the control. The increase in cell death is 
dose-dependent at day 2. The sample irradiated with 10 Gy shows a steep rise of the cell 
death rate up to about 38%. On day 3 after exposure, all samples including the control 
have increased cell death levels around 15%, again probably due to nutrition limitations 
of the cultures. The dose-effect is no longer measurable. 
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Figure 3.5 Cell death measured in cells immediately reseeded after exposure to carbon ions. 
After DAPI staining the fraction of apoptotic cell nuclei was counted. Data show the mean value 
of two independent experiments where the error bars express the standard error of the mean. 
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Figure 3.6 Cell death measured in cells immediately reseeded after exposure to x-rays. After 
DAPI staining the fraction of apoptotic cell nuclei was counted. Data show mean values of 
different independent experiments. Error bars express the standard error of the mean or Poisson 
distribution (details are given in table A.1). 
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Conclusively, data points from day 3 after reseeding (equals to day 3 after exposure) 
indicate a bias by the culture conditions. At day 1 after exposure to both x-rays and 
carbon ions, only the high doses show an increased level of apoptosis compared to the 
control. Low doses do not or only slightly exceed the background level of cell death 
estimated with 2.3% (± 0.3%). Two days after exposure to both radiation qualities 
instead, all irradiated samples have a dose-dependent higher level of cell death compared 
to the control. 
At two days after exposure carbons ions are more effectively inducing apoptosis than x-
rays. Apoptosis levels in samples exposed to carbon ions are about twice as high as in 
those exposed to x-rays. Thus, comparing 3 Gy of carbon and 6 Gy of x-rays on day 1 
after exposure, carbon ions induce apoptosis earlier, however, 6 Gy data are obtained 
from one experiment only. 
 
The percentages of cell death two, three and four days after exposure to carbon ions and a 
subsequent passage are shown in figure 3.7. On day 2 and 3 after exposure, the cell death 
rates of the lower doses 0.5 and 1 Gy are only slightly increased compared to the control. 
Cells irradiated with 2 and 3 Gy of carbon ions instead display a significant dose-
dependent increase in apoptotic cell death (p < 0.05, t test, except for 2 Gy on day 3). On 
day 4 after exposure, the percentages of cell death in the 0.5 Gy sample and the control 
are both higher than compared to day 2 and 3. The levels of the higher doses instead are 
decreased if compared to day 2 and 3 and are now close to all others. No dose-
dependence is observable here as apoptosis may be influenced by the culture conditions 
when cells remain for three days without passage or medium change. 
 
The cell death data after exposure to x-rays and a subsequent passage, as presented in 
figure 3.8 show only a slight increase for the 3 Gy irradiated sample two days after 
exposure. While the percentage of cell death of the control remains on a similar level 
three days after exposure, the irradiated sample rises steeply. On day 4 after exposure, 
both control and irradiated sample show an elevated level of cell death compared to their 
very levels before, but the difference between them is within the uncertainty of the error 
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bars. The apoptotic frequency is also here biased by the culture conditions as mentioned 
above. 
 
Figures 3.7 and 3.8 reveal that reseeding one day after exposure partly attenuates the cell 
killing effect of radiation in the cultures. On day 2 after exposure (first day after 
reseeding) to carbon ions doses up to 1 Gy do not differ significantly from control levels 
as the case in measurements without delayed reseeding (0.5 Gy, see figure 3.5). At day 2, 
also the apoptosis level following 3 Gy carbon ions exposure is lower than without the 
passage but it increases again to it the following day. Data for 3 Gy x-rays (figure 3.8) 
also show attenuation of the cell death on day 2 due to delayed reseeding and a 
subsequent increase one day later. But the apoptosis rate remains lower than in the 
experiments without delayed reseeding. Taken together, apoptosis, when cells are 
reseeded one day after the exposure is attenuated temporary but increases again, pointing 
to a delayed but persistent of cell death through the passage. 
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Figure 3.7 Cell death after exposure to carbon ions. Cells were passaged one day after exposure 
(black arrow). After DAPI staining the fraction of apoptotic cell nuclei was counted. Data show 
mean values of different independent experiments. Error bars express the standard error of the 
mean or Poisson distribution (details are given in table A.2). 
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Figure 3.8 Cell death after exposure to x-rays. Cells were passaged one day after exposure 
(black arrow). After DAPI staining the fraction of apoptotic cell nuclei was counted. Data were 
gained from one experiment where the error bars show the Poisson distribution. 
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Figure 3.9 Cell death measured after exposure to x-rays. Cells were reseeded immediately 
following exposure. X-fold increase of caspase-3 activity normalized to control (1-fold) is 
displayed. The values were obtained from one experiment. The error was estimated with ± 1-fold 
according to experimental experience with this assay. 
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Apoptosis was analysed in a few samples by the caspase-3 activity assay, to proof the 
data acquired by morphological analysis apoptotic nuclei. Results of the caspase-3 assay 
after irradiation with x-rays (cells reseeded immediately after exposure) are shown in 
figure 3.9. On day 1 after exposure there are only slight increases for samples irradiated 
with 1 (about 1.5-fold) and 3 Gy (about 2.5-fold), but the 6 Gy sample (about 3.5-fold) 
differs more from the control. Dose-dependent increases in apoptosis become pronounced 
two days after exposure. The cell death rate in 6 Gy and 3 Gy samples was elevated about 
9-fold and 4-fold, respectively. The 1 Gy sample is only slightly but not significantly 
increased as can be inferred from its error bars. At three days after exposure no 
differences to the control are detectable anymore. 
These results are comparable to the data of figure 3.6, where cell death was assessed by 
counting apoptotic nuclei. For both assays one day after exposure only the samples 
irradiated with 6 Gy exhibit an increase clearly different from controls while all other 
samples show no or only slight rises in cell death. In both cases, significant and dose-
dependent effects are only seen two days after exposure. Furthermore, three days after 
exposure with both assays no or only slight differences are measurable anymore between 
control and irradiated samples. The analysis with the caspase-3 activity assay hence 
verifies the data acquired by counting apoptotic nuclei. 
 
3.3 Differentiation of pluripotent ES-D3 cells after irradiation 
 
Proliferating pluripotent ES-D3 cells were exposed to radiation followed by a 
differentiation into spontaneously contracting cardiomyocytes. Differentiation was 
performed by creating EBs. 
 
3.3.1 Fraction of beating embryoid bodies on day 10 of differentiation 
 
The appearance of spontaneously contracting cardiomyocytes in the EBs was examined 
to measure the influence of radiation on the cardiac development. The assay is based on 
the Embryonic Stem Cell Test. In accordance, the effects were measured 10 days after the 
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initiation of differentiation. As mentioned above, differentiation was performed by two 
methods, i.e. with differentiation begin either directly (0h) or 72h after exposure. 
 
Figure 3.10 shows the fraction of spontaneously beating EBs 10 days after initiation of 
the differentiation for different doses. Control levels were set to 1. For cells differentiated 
directly after exposure (0h), dose-dependent inhibition occurs for both radiation qualities. 
Carbon ions are about twice as effective as x-rays when comparing iso-effective doses 
(see table 4.1). The fraction of beating EBs is lower (about 2.5%) for 3 Gy carbon ions 
and 6 Gy x-rays. In contrast, for 72 h experiments, x-rays do not affect the differentiation 
into beating cardiomyocytes. While carbon ions still inhibit the development of beating 
EBs, even at the lowest dose examined (0.5 Gy). The effect of the differentiation 
potential still is dose-dependent, although less pronounced than for 0h. Interestingly, the 
dose-effect curve for carbon ions at 72h is similar to the one for x-rays at 0h. 
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Figure 3.10 Dose-effect curves of carbon ions and x-rays on the development of spontaneously 
contracting cardiomyocytes. The fraction of beating EBs was determined on day 10 of 
differentiation and plotted semi-logarithmically against the dose. Control levels were set to 1. 
Differentiation was initiated directly after exposure (0h) or 72h after exposure. Data show mean 
values of different independent experiments. Error bars express the standard error of the mean or 
Bernoulli distribution (details are given in table A.3). 
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3.3.2 Developmental kinetics of beating embryoid bodies during the 
differentiation period 
 
To examine whether ionising radiation affect the developmental processes the emergence 
of spontaneously contracting cardiomyocytes in EBs was measured between day 10 and 
day 30 of differentiation. Data were plotted as the cumulative fraction of beating EBs, i.e. 
EBs were counted as positive if they had been beating at least once. Commonly, 
contraction can be monitored for several days after differentiation begin, however, some 
of the EBs can stop contraction activity earlier. This stop of the spontaneous beating was 
not taken into account here. Data were acquired here again for both differentiation 
methods performed, immediately after irradiation (0h) and with a delay of 72h after 
irradiation of pluripotent ES-D3 cells. 
 
Data obtained for cells differentiated immediately after exposure to carbon ions is shown 
in figure 3.11. The control shows a high level of beating EBs (96%) on day 10. The 
progeny of irradiated cells display a pronounced dose-dependent delay in development of 
contracting cardiomyocytes with 77% for 0.5 Gy and 4% (p < 0.01, t test) for 3 Gy on 
day 10. Over time, their fractions of beating EBs increase continuously. On day 21 the 
samples irradiated with 0.5 Gy reach 92% and thus almost the control level, considering 
the error bars. The 3 Gy irradiated sample still exhibits a significantly lower level of 
beating EBs than the control. Data points on days 25 and 30 were obtained from only one 
experiment. This might be the reason for the decrease in the curve of 0.5 Gy on day 25. 
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Figure 3.11 Cumulative fraction of beating embryoid bodies differentiated 0h after exposure to 
carbon ions. Data show mean values of different independent experiments. Error bars express the 
standard error of the mean or Bernoulli distribution (details are given in table A.4). To guide the 
eye, polynomial fits are superimposed on the obtained values. 
 
Figure 3.12 depicts the results for x-rays of differentiations started immediately after 
exposure (0h). Here again, the cumulative fraction of beating EBs for the control is high 
from the beginning and remains at the same level (99%) throughout the differentiation 
period. A dose-dependent significant decrease (according to the t test) in the formation of 
beating EBs is seen for all three applied doses (1, 3 and 6 Gy) on day 10 with 73, 35 and 
1%, respectively. The cumulative fractions for all irradiated samples rise throughout the 
differentiation period. At day 25, the data for 1 Gy are slightly lower, probably due to the 
fact that this point is obtained from one experiment only. Nevertheless, for 1 Gy the 
cumulative fraction of beating EBs (i.e. around 90%) approaches the control level. 
Similarly, the fractions to of 3 and 6 Gy develop. Taken together, the previous dose-
dependency vanishes at the last two time-points of the differentiation for the irradiated 
samples, but all reach the control level. 
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Figure 3.12 Cumulative fraction of beating embryoid bodies differentiated 0h after exposure to  
x-rays. Data show mean values of different independent experiments. Error bars express the 
standard error of the mean or Bernoulli distribution (details are given in table A.5). To guide the 
eye, polynomial fits are superimposed on the obtained values. 
 
The emergence of spontaneous contraction in EBs from cells differentiated 72h after 
exposure to carbon ions is shown in figure 3.13. The beating fraction in the control on 
day 10 was 87%, while a lower cumulative fraction of beating EBs is seen in all 
irradiated samples. However, the effect has no clear dose-dependence, as data for 1 and 
2 Gy suggest (see table A.6). Throughout the differentiation period all fractions rise. 
Control and 0.5 Gy irradiated samples finally reach 100% levels. As the fractions 
increase over time, differences between doses vanish and reach the control level. The 
3 Gy exposed sample has a significantly (p < 0.01, t test) reduced fraction of beating EBs 
until the last data point (day 30, 89%). 
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Figure 3.13 Cumulative fraction of beating embryoid bodies differentiated 72h after exposure to 
carbon ions. Data show mean values of different independent experiments. Error bars express the 
standard error of the mean or Bernoulli distribution. For reasons of clarity data sets for 1 and 2 
Gy are not plotted (complete set of data and further details are given in table A.6). To guide the 
eye, polynomial fits are superimposed on the obtained values. 
 
Figure 3.14 depicts the results of differentiation experiments started 72h after exposure to 
x-rays. Taking into account the error bars the differences between the control and all 
samples are low during the time interval investigated. The inhibition of differentiation 
into beating cardiomyocytes was not dose-dependent here. Even the sample exposed to 6 
Gy (85%) does not exhibit any inhibition compared to the control. The cumulative 
fraction of beating EBs increases for all doses during the differentiation period, 
confirming observations from other experiments (figures 3.11 to 3.13). Decreases for the 
control and the 3 Gy curve are due to different numbers of experiments used for 
calculations (two and three, respectively). Interestingly, the 2 Gy exposed sample is 
slightly higher than the other samples until day 21. Data points for samples exposed to 
1 Gy of x-rays are consistent with the other data sets and lie within the same range. For 
clarity, data for 1 Gy irradiated samples are not presented in the plot (see table A.7). 
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Figure 3.14 Cumulative fraction of beating embryoid bodies differentiated 72h after exposure to 
x-rays. Data show mean values of different independent experiments. Note the different y-axis 
scaling. Error bars express the standard error of the mean or Bernoulli distribution. For reasons 
of clarity data sets for 0.5, 1 and 6 Gy are not plotted (complete set of data and further details 
are given in table A.7). To guide the eye, polynomial fits are superimposed on the obtained 
values. 
 
Data from chapter 3.3.1 showed that carbon ions were about twice as effective as x-rays 
in inhibiting differentiation into beating cardiomyocytes on day 10 of differentiation. The 
developmental kinetics of beating cardiomyocytes for 0h experiments (figures 3.11 and 
3.12) showed a similar behaviour for iso-effective doses (i.e. 0.5 Gy and 3 Gy carbon 
ions versus 1 Gy and 6 Gy x-rays, respectively), confirming the RBE of about 2. 
Fractions of beating EBs for all doses of both radiation qualities reached the control level 
within the time interval investigated (up to day 30). Fractions of iso-effective doses 
reached similar levels. For 72h experiments (3.3.1), an inhibition of the development of 
beating cardiomyocytes was observed only after carbon ion exposure but not after x-ray 
exposure. Hence, an RBE estimation cannot be done. However, data from 3.3.1 revealed 
a similarity between the curves for 0h x-rays and 72h carbon ion. This similarity was also 
seen in the developmental kinetics when comparing the data obtained for 3 Gy, carbon 
ions or x-rays (figures 3.12 and 3.13). For 72h x-rays, the developmental kinetics did not 
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significantly differ from the control kinetic. Only the data points of 2 Gy exposed 
samples instead were slightly higher than all other samples (see chapter 4.5.1). 
 
The RBE values for carbon ions in 0h experiments of developmental inhibition of 
contracting cardiomyocytes (3.3.1) and the cell inactivation (3.2.1) were close to each 
other (2 and 3, respectively). Additionally, developmental kinetics of beating 
cardiomyocytes between iso-effective doses in 0h experiments were similar. That 
indicates an influence of the initial cell number when EBs aggregate on the beating 
fraction obtained from them. The initial cell number might be altered by cell killing 
effects of radiation in the nascent EB. Vice versa, the similarity of kinetics between 72h 
carbon ions and 0h x-rays were not found in the cell survival experiments. 
 
3.3.3 Size of embryoid bodies from exposed cells 
 
The diameter of EBs was measured on day 5 of differentiation to assess the putative 
influence of radiation exposure on cell growth and the differentiation to contracting 
cardiomyocytes. For diameter measurements, day 5 was chosen for two reasons. First, on 
that day single EBs were transferred in the cavities of 24-well tissue culture dishes. 
Second, by that time, right before the attachment, they still show a regular spheroid size 
that later changes to irregular structures that are difficult to measure. EBs used here were 
the very same ones used for determining the beating fraction on day 10 of differentiation 
(see above) for cells differentiated 0h or 72h after exposure to x-rays or carbon ions. 
 
Figure 3.15 relates the size of EBs to the fraction of beating EBs after exposure to both 
carbon ions and x-rays. Differentiation was started immediately after exposure (0h). For 
comparison, the fractions of beating EBs after exposure are replotted from figure 3.10. 
With an increasing dose, the diameter of the EBs decreases. The twice higher 
effectiveness of carbon ions also appears in the diameter reduction. Controls in both cases 
are around 450 µm. The lowest dose each (0.5 Gy carbon ions and 1 Gy x-rays) results in 
a moderate decline of size to about 400 µm (carbon ions) and 430 µm (x-rays), 
respectively. The size reduction is not significant according to the t test. For 3 Gy carbon 
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ions and 6 Gy x-rays, the diameter of the EBs is about 250 µm. The error bars here are 
clearly separated from the ones of the control, underlining the significance (p < 0.01, 
t test). Hence, the reductions in size for low doses are moderate whereas response to the 
higher doses is rather strong. This corresponds to the moderate and strong reductions in 
the fraction of beating EBs for low and high doses, respectively. 
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Figure 3.15 Size of embryoid bodies and fraction of beating embryoid bodies after exposure to 
carbon ions and x-rays (differentiation initiation at 0h). The diameter of the bodies was measured 
on day 5 of differentiation immediately after seeding in 24-well tissue culture plates. Beating 
fractions were determined five days later (day 10 of differentiation). Data show mean values of 
different independent experiments. Error bars express the standard error of the mean or 
Bernoulli distribution (details are given in table A.8). 
 
Similarly the size of EBs and its relation to the fraction of beating EBs after exposure to 
both carbon ions and x-rays was examined for cells differentiated 72h after exposure 
(figure 3.16). The fractions of beating EBs after exposure is replotted from figure 3.10. 
For carbon ions, the size of the EBs is smaller for 0.5 Gy (about 400 µm) than for 
controls (about 500 µm). The size of EBs for 3 Gy irradiated samples is reduced to about 
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300 µm. Significantly different from the control, however, are only the 2 Gy exposed 
sample (p < 0.05, t test) and the 3 Gy exposed sample (p < 0.01, t test). Interestingly, the 
differences between the various irradiated samples are less pronounced, resembling the 
reduction of the fraction of beating EBs (figure 3.16, upper panel). The control value of 
EB-size in the x-ray experiments is in the same level of the controls value for carbon ion 
experiments (about 500 µm). The samples exposed to 3 Gy x-rays show a strong decrease 
(p < 0.01, t test) in size of the EBs, however, there is no data for any other dose 
concerning the EB diameter. The samples exposed to x-rays instead do not differ from 
controls concerning the fraction of beating EBs. 
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Figure 3.16 Size and beating fraction of embryoid bodies after exposure to carbon ions and x-
rays (differentiation initiation at 72h). The diameter of the bodies was measured on day 5 of 
differentiation right after seeding in 24-well tissue culture plates. Beating fractions were 
determined five days later (day 10 of differentiation). Data show mean values of different 
independent experiments. Error bars express the standard error of the mean or Bernoulli 
distribution (details are given in table A.9). 
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Altogether, the data from both 0h and 72h experiments suggest a dependence of the 
fraction of beating EBs on the EB size and thereby also a dependence on the cell number. 
The 3 Gy x-rays exposed sample in the 72h experiment, however, is an exception as size 
was reduced but no influence on the development of EBs was found. 
 
3.3.4 Cell proliferation in embryoid bodies differentiated from 
exposed cells 
 
Cell proliferation was measured in EBs on day 5 of differentiation of a 0h experiment to 
investigate whether 3 Gy of x-rays still affect the number of cycling cells after a time 
span of five days. The cell proliferation was measured by quantifying EdU-positive cells 
with flow cytometry or by fluorescence microscopy. Flow cytometer analysis revealed an 
increase in cell proliferation in EBs differentiated from cells exposed to 3 Gy x-rays. The 
increase was 1.7-fold (± 0.2, error estimation based on experimental experience with this 
assay) when compared to the control. No difference between control and exposed sample 
was found when EdU-positive cells were analysed by fluorescence microscopy (49% ± 
2% error calculated with Poisson distribution). Both data sets were derived from the same 
experiment. Flow cytometer data were gained through processing the raw data by several 
gating steps and finally an arbitrary threshold was chosen to compare control and 
exposed sample. This data processing, however, can impair the significance of the data. 
Therefore, results obtained by scoring EdU-positive cells with a microscope may be 
considered more robust in that case .In conclusion, the data suggest that differences in the 
proliferation rate between control and the exposed sample are unlikely. This indicates 
that the cells might have overcome damaging radiation effects on day 5 of differentiation. 
 
3.3.5 Effect of the initial cell number on the emergence of 
spontaneously contracting cardiomyocytes 
 
To disentangle the influence of initial cell number and radiation on the cardiomyocyte 
development, EBs were produced from 500, 750 and 800 cells, respectively, 72h after 
exposure to 2 Gy of carbon ions (figure 3.17). The standard protocol as used in all other 
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experiments is 750 cells. The controls do not show a dependence on the used initial cell 
numbers. On day 10 they exhibit high fractions of beating EBs (around 85%) that 
increase during the differentiation time observed (until day 21 after differentiation 
initiation). A similar fraction of beating EB was found after irradiation with 2 Gy and 
850 cells seeded. EBs generated from 750 and 500 exposed cells instead have a lower 
fraction of beating EBs (53 and 42%, respectively). The fraction of beating EBs declines 
with a lower cell number. Their fractions, however, increase over the time-course 
observed. The fraction of the initial cell number of 750 cells exposed to 2 Gy carbon ions 
finally reaches the levels of the other, the 500 cell sample instead does not reach it during 
that period. 
 
0,2
0,3
0,4
0,5
0,6
0,7
0,8
0,9
1,0
8 10 12 14 16 18 20 22
Days after differentiation initiation
Cu
m
u
la
tiv
e
 
Fr
a
c
tio
n
 
o
f b
e
a
tin
g 
EB
0 Gy 750 cells
0 Gy 850 cells
0 Gy 500 cells
2 Gy 750 cells
2 Gy 850 cells
2 Gy 500 cells
C-ions, 72h
Cu
m
u
la
tiv
e
 
Fr
a
c
tio
n
 
o
f b
e
a
tin
g 
EB
 
Figure 3.17 Relationship between initial cell number and fraction of beating embryoid bodies 
after exposure to carbon ions (differentiation initiation at 72h). Samples with 750 (standard 
protocol) initially seeded cells are replotted from figure 3.13. Data sets for 500 and 850 initially 
seeded cells are derived from one experiment. Error bars express the standard error of the mean 
or Bernoulli distribution. For reasons of clarity only two curves of the data sets with higher 
fractions are presented with error bars depicting the outermost error in this group (details are 
given in table A.10). 
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Taken together, the results here indicate that in control samples a different initial cell 
number in the EBs alone (500, 750 and 850 cells of control) has no influence on the 
fraction of beating EBs. When the reduced initial cell number is combined with radiation 
(2 Gy of carbon ions), differences emerge. 
 
3.3.6 Cell death in embryoid bodies 
 
The number of cells undergoing apoptosis in the EBs after radiation exposure was 
measured at day 1, 3 and 5 of differentiation. Both differentiation protocols, 0h and 72h 
were applied. The background level for cell death in control EBs was found to be 
12% ± 1% (n=7), 38% ± 6% (n=7) and 32% ± 6% (n=5) on days 1, 3 and 5 of 
differentiation (0h and 72h experiments), respectively. Hence, apoptosis rate for controls 
is higher in EBs than in pluripotent cultures (see chapter 3.2.2). 
 
Figure 3.18 demonstrates that cell death in EBs, differentiated immediately after 
exposure (0h) to carbon ions is only affected by radiation on day 1 of differentiation. The 
level of apoptosis is around 10%, whereas it is significantly higher in the 3 Gy exposed 
sample (i.e. around 27%, p < 0.01, t test). The cell death level of the sample exposed to 
0.5 Gy slightly increases on day 1. On days 3 and 5 of differentiation no dose-dependent 
effect was detected. In general, the cell death rate on day 3 of development rises but 
decreases on day 5. 
 
For doses up to 3 Gy x-rays, cell death in EBs differentiated immediately after exposure 
(0h) does not show any dose-effect, as demonstrated in figure 3.19. Apoptosis rates for 1 
and 3 Gy irradiated samples rise from day 1 to day 5 of differentiation (i.e. one, three and 
five days after exposure, respectively), but are close to the control levels (roughly 13% to 
39%). In contrast, the sample exposed to 6 Gy exhibits an increased rate of cell death 
(about 36%) only on day 1 of differentiation when compared to control, 1 and 3 Gy 
exposed samples. Highest numbers of cell death were found for the sample exposed to 10 
Gy as it has a significant increase at both time points (around 48% and 76%, respectively) 
each compared to the control. It rises further on day 3 and remains higher than the 
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control. Data for the 10 Gy sample could not be assessed as EBs had disaggregated after 
few days of differentiating. 
 
In summary, apoptosis levels in EBs differentiated directly after exposure to carbon ions 
were dose-dependently elevated only one day after exposure. For x-rays, only doses 
higher than 3 Gy exceeded the cell death level of the control on day 1. An exception is 
the 10 Gy exposed sample that also exhibited an increased level of cell death three days 
after irradiation. When comparing 0.5 Gy of carbon ions on day 1 to 1 and 3 Gy of x-
rays, carbon ions were more effective in inducing apoptosis. Doses of 3 Gy carbon ions 
and 6 Gy x-rays had an iso-effect for other endpoints, however, here they did not. 
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Figure 3.18 Cell death in embryoid bodies after exposure to carbon ions, 0h experiments. EBs 
were dissociated to single cell suspension. After DAPI staining the fraction of apoptotic cell 
nuclei was counted. The red numbers indicate the days of differentiation. Data show the mean 
value of two independent experiments where the error bars express the standard error of the 
mean. 
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Figure 3.19 Cell death in embryoid bodies after exposure to x-rays, 0h experiments. EBs were 
dissociated to single cell suspension. After DAPI staining the fraction of apoptotic cell nuclei was 
counted. The red numbers indicate the days of differentiation. Data show mean values of different 
independent experiments. Error bars express the standard error of the mean or Poisson 
distribution (details are given in table A.11). 
 
Cell death in EBs where differentiation began at 72h after exposure to carbon ions is not 
affected by radiation in a dose-dependent manner (figure 3.20): on day 1 of 
differentiation (four days after exposure) the apoptosis rates are around 13% in all 
samples. On differentiation day 3 the cell death rate rises to about 38% for all samples 
and remains on that level on day 5 of differentiation for most samples, except for 0.5 Gy 
(about 25%), which decreases at that time point. 
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Figure 3.20 Cell death in embryoid bodies after exposure to carbon ions, 72h experiments. EBs 
were dissociated to single cell suspension. After DAPI staining the fraction of apoptotic cell 
nuclei was counted. The red numbers indicate the days of differentiation. Data show mean values 
of different independent experiments. Error bars express the standard error of the mean or 
Poisson distribution (details are given in table A.12). 
 
The cell death rates in EBs where differentiation was started 72h after irradiation with 3 
Gy x-rays are displayed in figure 3.21. The differences between control (about 15%) and 
the exposed sample (about 18%) are small on day 1 of differentiation. However, the 
differences increase slightly over time and the cell death rate of the exposed sample 
remains higher. Cell death rates in general rise on day 3 of differentiation (43% control 
and 49% exposed sample) and remain on that level on differentiation day 5 (42% control 
and 50% exposed sample). 
 
Data obtained so far indicate that radiation-induced apoptosis in EBs differentiated 72h 
after exposure to carbon ions and x-rays is minimal. 
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Figure 3.21 Cell death in embryoid bodies after exposure to x-rays, 72h experiments. EBs were 
dissociated to single cell suspension. After DAPI staining the fraction of apoptotic cell nuclei was 
counted. The red numbers indicate the days of differentiation. Data are from one experiment 
where the error bars express Poisson distribution. 
 
Comparing the apoptosis rates after radiation exposure in pluripotent ES-D3 cultures and 
in EBs, points out that radiation induced cell death was measurable in ES-D3 up to day 3 
after exposure, particularly when a passage was done one day after irradiation. In EBs 
however, a radiation induced increase in the apoptosis was only seen one day after 
exposure in 0h experiments. After the passage and a subsequent differentiation (72h 
experiments) radiation-induced apoptosis was not distinguishable. Hence, cell death 
induction by radiation was lower in EBs generated from irradiated ES-D3 than in 
exposed pluripotent ES-D3 cultures, probably due to the higher background level of 
apoptosis in the controls per se (see chapter 4.5.4). This higher background of apoptosis 
in later EB stages (38% and 32%, respectively) hampered the measurement of radiation-
induced apoptosis in that system. 
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3.3.7 Mathematical modelling of the fraction of beating embryoid 
bodies  
 
To gain further information about the contribution of the initial cell number seeded for 
EB formation on the fraction of beating EBs and its developmental kinetics over the 
differentiation time-course, a mathematical model was applied. The model reflects the 
contribution of the initial cell number influenced by radiation-induced cell inactivation 
and connects it with the probability of the EBs to show contraction. The data as presented 
in 3.3.2 were thus modelled. 
 
The modelled data for the differentiation 0h after exposure to carbon ions (figure 3.22) 
are exemplarily shown compared to the measured fraction of beating EBs on day 10 of 
differentiation. The reproduced data are not in agreement with the measured data. While 
the fraction of beating EBs for the measured data was inhibited dose-dependently, the 
reproduced data do not show any inhibition at all. Additionally, for the other experiments, 
i.e. 0h x-rays, 72h carbon ions an x-rays the modelled data were not in agreement with 
the measured data neither. No inhibition for any dose was found (graphs not shown). The 
model thus was not able to reproduce the experimentally obtained data. Hence, no 
conclusion on whether the initial cell number reduced by radiation plays a pivotal role 
can be drawn from it. 
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Figure 3.22 Measured and modelled data for the cumulative fraction of beating embryoid bodies 
differentiated 0h after exposure to carbon ions. Measured data are redrawn from figure 3.11. 
 
3.3.8 Expression of pluripotency and cardiac marker genes in 
embryoid bodies derived from exposed cells 
 
Putative effects of 3 Gy carbon ions or x-rays on the transcript expression of genes 
related to pluripotency and cardiomyocytes were studied by qRT-PCR. 
 
Figure 3.23 displays the expression of pluripotency-associated marker genes, i.e. Nanog, 
Sox2 and Oct-3/4. For controls, the expression levels of Nanog and Sox2 both are highest 
on day 0 (undifferentiated state) and decrease constantly over the differentiation time-
course. A decrease was found as well for the samples exposed to x-rays. However, the 
Sox2 expression decreases slower in x-ray irradiated samples than in the controls. The 
levels of the samples exposed to carbon ions for Sox2 and Nanog instead do not decrease 
but remain at the same level with minor fluctuations. A different expression pattern was 
found for Oct-3/4. In controls and irradiated samples an increase in the expression was 
measured when compared to the control of day 0, followed by a decline. That decline in 
expression levels is more pronounced for the control than after exposure. The least 
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change in expression was found for samples irradiated with carbon ion. The rise in the 
expression levels in the early differentiation period found in all samples may be related 
with another function of Oct-3/4 during the incipient differentiation as discussed in 
chapter 4.2. A pronounced difference between high- and low-LET was found for all three 
investigated genes. 
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Figure 3.23 Expression of pluripotency marker genes in embryoid bodies differentiated 0h after 
exposure to carbon ions and x-rays. Expression is normalized to undifferentiated control cells 
(day 0 after differentiation initiation). Data are obtained from three technical replicates of one 
experiment and error bars represent their standard error of the mean. 
 
The ongoing differentiation may serve as an explanation for the decrease in the 
expression of the pluripotency-associated genes over the observed time-course. The 
differences between control and the various exposed samples (higher RBE for carbon 
ions) were found as well for the inhibition of differentiation into beating cardiomyocytes. 
The initial fractions of beating EBs and the resulting delayed increase of the fractions 
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were found to be more affected by carbon ions (3.3.1 and 3.3.2, respectively). Therefore, 
a relation between the delayed cardiac differentiation and the delayed decrease of the 
pluripotency-associated gene expression is likely. 
 
Complementing the pluripotency gene studies over the time-course of differentiation, the 
gene expression of cardiac differentiation markers was studied using the same samples 
(figure 3.24). Generally, expression levels of all investigated genes are low in the 
beginning and increase up to day 10, demonstrating the onset of cardiac differentiation. 
Concerning the gene expression of the transcription factor Gata4, the control and the 
sample from EBs exposed to x-rays increase over time and from day 10 on remain at a 
certain level with minor fluctuations. The EBs derived from cells exposed to carbon ions 
instead show a slower increase in the expression and reach the levels of the other samples 
not before day 21. The peak in the expression on day 25, due to the fact that the results 
are from one experiment, may be considered an outlier. For Hcn4, the ion channel 
protein, expression in the control increase after day 10. That was found as well for 
samples exposed to carbon ions and x-rays, although slower. While the expression in 
control and x-rays exposed samples apart from minor fluctuations rise, it declined in 
samples irradiated with carbon following day 21 of differentiation. Generally, a delay 
through exposure was found also for Hcn4. Concerning the three structural and functional 
markers Myh7, cAct and cTropT2 analysed, the gene expression levels in the controls 
decrease after day 10 of differentiation. The exposed samples show a delayed rise in 
expression compared to the control, i.e. Myh7 and cTropT2 reach the peak value of the 
control later. For cAct, there is a delay for exposed samples, too, but the control level is 
not reached. The high expression for carbon ions on day 30 is probably an outlier. 
Thus, the data indicate that the delayed increase of the cardiac marker gene expression 
consequentially follows the delay in the decrease of pluripotency-associated genes and 
reflects the developmental kinetics of cardiomyocyte emergence. 
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Figure 3.24 Expression of cardiac marker genes in embryoid bodies differentiated 0h after 
exposure to carbon ions and x-rays. Expression is normalized to the control on day 10 after 
differentiation initiation. Data are obtained from three technical replicates of one experiment and 
error bars represent their standard error of the mean. 
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4. Discussion 
 
 
4.1 Risk of an unanticipated radiation exposure of the early 
embryo 
 
The influence of ionising radiation exposure during the early embryonic development 
(pre-implantation stage) is insufficiently understood, however, it is of interest for public 
health to gain information on that topic. To date, that information is mainly derived from 
experimental in vitro data or animal studies. Most studies focus on low-LET radiation. 
They point out a high radiation sensitivity of the embryo throughout the whole prenatal 
period in utero (for a summary see ICRP 2003). The data further suggest lethality as the 
dominating effect of radiation exposure in the pre-implantation period starting from doses 
of about 0.1 Gy of low-LET radiation. Malformations following an exposure in the pre-
implantation stage have been also observed, but seem to depend on a genetic 
predisposition of the mouse strain [Streffer 2006]. Experiments with neutrons provide the 
only data for high-LET radiation and suggest a higher RBE when compared to x-rays 
[e.g. Pampfer and Streffer 1988]. Most of these data however are derived from 
experiments when embryos were exposed in the zygote stage [e.g. Weissenborn and 
Streffer 1988]. With ongoing development, even within the pre-implantation stage, the 
probability of a lethal effect declines rapidly. Thus, an LD50 (dose leading to lethality in 
50% of the cases) from the zygote stage to the blastocyst stage, both still pre-
implantational, was estimated to be 1 Gy. The lethality according to the report is mainly 
due to cytogenetic damage and chromosomal aberrations that develop in the rapidly 
dividing cells, although DNA repair seems to be efficient [European Commission 2002, 
ICRP 2003]. 
 
Humans are exposed to a natural background level of ionising radiation, which can 
penetrate tissues deeply. That background level is about 2 mSv per year. Additionally, 
exposure comes from radiation sources such as diagnostic applications, security scans at 
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airports and flights. X-ray diagnostics for example contribute with another 1.8 mSv per 
year and per capita [Bundesamt fuer Strahlenschutz 2001, Bundesamt fuer Strahlenschutz 
2009]. The likelihood of foetal radiation exposure additionally to the natural background 
hence is high. About 50% of all pregnancies in North America for example are unplanned 
[Pennsylvania Patient Safety Advisory 2008]. Thus, especially in the pre-implantation 
phase, the pregnancy might still be unknown to many expectant mothers and an 
unanticipated radiation exposure of the embryo through diagnostic or therapeutic means 
is of concern in that context. A computed tomography (CT) scan on the abdomen for 
example can result in a foetal radiation dose of 30 mGy (about 10 mSv). To compare, the 
natural foetal background dose is about 1 mGy and the Radiation Safety Committee of 
the United States Centers for Disease Control and Prevention recommends not to exceed 
a cumulative foetal dose of 5 mGy [Ratnapalan et al. 2003, Pennsylvania Patient Safety 
Advisory 2008]. Furthermore, an unanticipated exposure can result from therapeutic 
application of radiation, as radiotherapy is an effective treatment for cancer patients. 
Approximately 50% of all patients with localized malignant tumours are treated with 
ionising radiation [Durante and Loeffler 2010]. 
The accident of Fukushima in March 2011 has shown recently that an accidental 
exposure of a large collective of people is a realistic scenario that can lead to an exposure 
with different qualities of ionising radiation [Doerr and Meineke 2011, Thielen 2012]. 
The same danger can emanate from nuclear attacks, for example through the explosion of 
a large radiologic dispersal device (“dirty bomb”) in a scenario of nuclear terrorism 
[Wolbarst et al. 2010, Williams and McBride 2011]. Given the exposure of a large 
collective of individuals, for instance in a densely populated city, it is likely that pregnant 
women are among them. 
 
Nontheless, data for high-LET radiation are rather rare but of great importance for 
radiation protection as well. About half of the 2 mSv natural background radiation comes 
from the inhalation of radon which produces high-LET alpha particles in its decay chain 
[Bundesamt fuer Strahlenschutz 2009, Newhauser and Durante 2011]. Taking flights, 
especially intercontinental ones with higher altitude, cosmic radiation partly comprised of 
high-LET particles contributes more to the exposure of a body than on earth [Singh et al. 
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2011a]. In nuclear disasters, for example from dirty bombs high-LET radiation may be 
emitted [Durante 2003]. Additionally, high-LET charged particles are increasingly used 
for therapeutic applications, such as proton or carbon ion radiotherapy or radiosurgery 
[Schardt et al. 2010, Bert et al. 2012]. Apart from the accuracy, which is one of the 
advantages of particle therapy, the creation of secondary particles, mainly neutrons due to 
fragmentation is a concern and its severity remains to be elucidated [Newhauser and 
Durante 2011]. However, Muenter et al. [2010] showed that particle therapy with carbon 
ions may be used to treat pregnant women for cancer keeping the in utero dose as low as 
the natural background. These facts point out the necessity for data on the effects of high-
LET radiation on the early embryonic development. To contribute to a better 
understanding of the risk during early embryonic development, the present study used the 
in vitro differentiation of mESC as a model. 
 
4.2 Pluripotency of the ES-D3 cultures 
 
The ES-D3 cell line, used in the present work as a model for embryonic development, 
was shown to have pluripotency potential by the formation of teratomas after injection in 
mice and by the creation of chimeras after injection in blastocysts [Doetschman et al. 
1985, Pease and Willimas 1990]. The term pluripotency describes the potential to 
differentiate into cells of all three primary germ layers (endoderm, mesoderm and 
ectoderm) and is related with unlimited self-renewal and proliferation of the cells. 
However, with ongoing differentiation they loose potency and finally remain as 
differentiated cells [Wobus and Boheler 2005]. The undifferentiated pluripotent stage of 
the ES-D3 used in the radiation experiments is an important prerequisite. Therefore, the 
used ES-D3 cultures were tested in regular periods while in culture for the expression of 
pluripotency markers.  
 
First, the activity of alkaline phosphatase was investigated (3.1.1). The expression of 
alkaline phosphatase was found in pre-implantation development in embryos and is a 
feature of pluripotent stem cells, although not being exclusively expressed by stem cells 
and early progenitors [Wobus et al. 1984, Hahnel et al. 1990]. The assay revealed that all 
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colonies in the cultures showed the red/purple staining indicating active alkaline 
phosphatase and thus pluripotency. This is in line with data from Toumadje et al. [2003] 
showing that all colonies of ES-D3 were positive for alkaline phosphatase. As depicted in 
figure 3.1, around the colonies, unstained cells with a different morphology from the cells 
inside the colonies were regularly found. The different shape and also the bigger size of 
these cells indicate that they may represent differentiated cells. 
 
Next, transcription factors that are crucial for pluripotency maintenance were 
investigated. These factors, together with others, interact with each other controlling and 
maintaining their expression levels and the pluripotency of the cell [Masui et al. 2007]. 
They are regulated by diverse signalling pathways, where LIF, which is present in the 
ES-D3 cultures also in this work is a main player regulating this network [for an 
overview see Annerén 2008]. Some of the key players in pluripotency maintenance are 
Oct-3/4, Sox2 and Nanog [Mullen et al. 2007, Wobus and Loeser 2011]. In this work, 
pluripotency of ES-D3 therefore was investigated by measuring gene expression with 
qRT-PCR as shown in 3.3.8. Oct-3/4, Sox2 and Nanog were expressed in the ES-D3 
cultures right before they were differentiated (day 0, figure 3.23). The highest expression 
of Sox2 and Nanog was found on day 0, i.e. in pluripotent cultures. Sox2 and Nanog are 
down-regulated when differentiating into mesoderm [Thomson et al. 2011], which is 
consistent with data shown in figure 3.23. Oct-3/4 expression pattern is an exception, as it 
first (day 4 of differentiation) rose and then decreased. However, it has been reported that 
an increase in the expression of Oct-3/4 is accompanied with a differentiation into 
endoderm and mesoderm [Niwa 2001]. The differentiation into mesodermal lineages and 
subsequently cardiac lineages is especially the case for the EST-like assay used in this 
work. In summary, alkaline phosphatase activity and the expression of Oct-3/4, Sox2 and 
Nanog, all four being markers for pluripotent mESC [Pera and Tam 2010] indicated that 
the ES-D3 cells used for the experiments here were pluripotent. 
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4.3 Influence of radiation on the pluripotency 
 
The influence of the radiation on the expression of pluripotency-associated genes was 
first measured on day 4 following differentiation initiation. As mentioned above, the 
decrease in expression of these genes was found. Samples exposed to 3 Gy x-rays and 
3 Gy carbon ions had a delayed decrease of Oct-3/4, Nanog and Sox2. EBs derived from 
the progeny of cells irradiated with 3 Gy x-rays all decreased the expression levels of 
Oct-3/4, Sox2 and Nanog, but slower than the control EBs. The EBs derived from the 
progeny exposed to 3 Gy carbon ions instead maintained their expression levels (Nanog 
and Sox2) or their level declined even slower (Oct-3/4) than in x-rays exposed samples. 
Given the same dose, high-LET radiation was more effective. Most likely, the reason for 
that is a delayed differentiation that does not result from a radiation-altered expression of 
pluripotency-associated genes, as discussed below. However, the progeny of irradiated 
ES-D3 kept their pluripotency potential as shown by the expression of marker genes of 
all three germ layers when differentiated [Arrizabalaga, unpublished data]. Data on the 
influence of radiation of the differentiation and the pluripotency potential are rare. Our 
data are in accordance with data published by Rebuzzini et al. [2012] who found that the 
survivors of the mESC line R1 irradiated with 5 Gy γ-rays maintained their pluripotent 
potential and were able to differentiate into the three germ layers. For hESC, exposed to 4 
Gy of γ-rays the capability of teratoma formation when injected in mice after irradiation 
was reported [Wilson et al. 2010], which is considered the definitive proof for 
pluripotency. Data for high-LET radiation for a comparison with the results found here 
are not available. 
 
The above-mentioned results were measured in differentiating cells that were derived 
from exposed pluripotent ES-D3 cells. Effects of radiation on pluripotency-associated 
gene expression in pluripotent ES-D3 cultures were investigated in the context of the 
present study, too. Luft et al. [2013b, submitted] could show that up to 17 days after 
exposure of ES-D3 cultures to carbon ions (up to 2 Gy) or x-rays (up to 3 Gy) no changes 
in the protein expression of Oct-3/4 and Sox2 occurred. Similarly, Rebuzzini et al. [2012] 
reported that 96h after radiation exposure the mESC line R1 after exposure to γ-rays still 
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expressed Oct-3/4 and two other pluripotency markers. Wilson et al. [2010] found for 
hESC, that survivors after exposure up to 4 Gy γ-rays still expressed Oct-3/4, Sox2 and 
Nanog. That was found as well for lower doses up to 1 Gy by Sokolov et al. [2010]. 
Available data are rare also here and no data at all were found up to date to compare with 
results for high-LET radiation. 
 
In conclusion, neither low-LET nor high-LET radiation in the doses used here could 
affect the expression in ES-D3 cell cultures, even several days after exposure. Effects of 
radiation and differences between low- and high-LET were found instead in 
differentiating EBs. However, these effects may be explained with a dependence on the 
cell number in the EBs as discussed below, and not primarily due to radiation-induced 
gene expression changes. 
 
4.4 Differentiation of embryonic stem cells to functional 
cardiomyocytes 
 
The basic method of the current work is the in vitro differentiation of the mESC line ES-
D3 into contracting cardiomyocytes, which is a broadly used and promising technique for 
research. The formation of functional, i.e. spontaneously contracting cardiomyocytes was 
among the first events to be described from mESC differentiation using EBs. In fact, 
derivation of cardiomyocytes from mESC is a frequent event in directed lineage 
differentiation [van Laake et al. 2005]. Wnt/β-catenin, transforming growth factor β 
(TGFβ), BMP and fibroblast growth factor (FGF) signalling is a crucial event to induce 
or promote in vitro differentiation into cardiomyocytes [van Laake et al. 2005, Murry and 
Keller 2008]. Nkx2.5 and Gata4 are among the earliest transcription factors expressed 
[Boheler et al. 2002, Kouskoff et al. 2005]. Other early markers of cardiac differentiation 
are Flk-1, insulin gene enhancer protein-1 (Isl-1) and Cripto-1 [Wei et al. 2005, Murry 
and Keller 2008]. The expression of these functional genes resembles the early 
cardiogenesis in the embryo and leads to in vitro-differentiated cardiomyocytes that share 
various features with their in vivo equivalents. Thus, in vitro-derived cardiomyocytes 
express structural and functional cardiac genes, some of which were used as marker to 
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study the cardiac differentiation in that work (see chapter 3.3.8). They may build 
organized bundles of myofibrils that are connected to each other in a network of gap 
junctions. The cardiac in vitro differentiation can give rise to a variety of specialized 
cardiac cell types [Maltsev et al. 1993, Boheler et al. 2002, Baharvand et al. 2006]. 
Cardiomyocytes generated in vitro were shown to have a spontaneous contraction activity 
[Doetschman et al. 1985]. Several days after differentiation begin beating foci arise 
within the EBs. Contractions can be seen from several days up to one month but 
cardiomyocytes can be kept in culture even beyond that. The electrophysiological 
properties of these cardiomyocytes can be assessed and are comparable with those of the 
in vivo situation [Boheler et al. 2002, Banach et al. 2003]. 
 
The EST is a generally accepted in vitro assay used to study embryotoxicity of drugs and 
other chemical compounds and is based on the differentiation of mESC (line ES-D3) into 
beating cardiomyocytes [Kuske et al. 2012]. In vivo studies for that purpose are time-
consuming and expensive [Scholz et al. 1999]. The EST, validated by the ECVAM offers 
an in vitro alternative for embryotoxicity testing of chemicals [Balls 2002, Scholz and 
Spielmann INVITTOX no. 113 2002]. Typical concentration-response curves can be 
derived of the EST to estimate the ID50 value (inhibition of cardiac cell differentiation to 
50% of a control). This value, together with cytotoxicity values derived from other 
accompanying assays, is used to classify chemical compounds or drugs either non-
embryotoxic, weakly embryotoxic or strong embryotoxic [Wobus and Loeser 2011, 
Seiler and Spielmann 2011]. Considering the at least 30000 chemical compounds to be 
classified for their effects on the human health in the Registration, Evaluation, 
Authorisation and Restriction of Chemicals (REACH) programme of the European 
Union, the EST may be useful but has not yet been accepted to completely replace animal 
testing [European Union 2006, Wobus and Loeser 2011]. However, the EST is under 
permanent revaluation to apply new aspects such as molecular markers or endpoints 
considering gene expression and to improve its features for high-throughput applications 
[e.g. Buesen et al. 2009, Groebe et al. 2010, Theunissen and Piersma 2012, Theunissen et 
al. 2013]. 
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Despite its promising features to screen embryotoxicity, the EST has up to date never 
been used to investigate the effects of ionising radiation on the early embryonic 
development. Especially the early embryonic development is similar between mammals 
[ICRP 2003]. Therefore the basic principle of the EST, the differentiation of ES-D3 cells 
into spontaneously contracting cardiomyocytes, was used in the current work to assess 
information on how radiation during the blastocyst stage affects the early cardiac 
development in mammals. 
 
A crucial step in establishing the EST-like assay was to improve the efficiency of the 
cardiac differentiation by testing different sera (chapter 3.1.2). All three tested sera 
resulted in an efficiency of 80% ± 10% when analysed on day 10 of differentiation. This 
is in the range of the official requirements for the validated EST (i.e. at least 87.5% in 
each run for the control) [Seiler and Spielmann 2011]. Hence, it provided enough beating 
EBs for statistically relevant results. 
 
Following the establishment of the cardiac differentiation of ES-D3 according to the 
recommended protocol, a validation using the EST-classified teratogen retinoic acid (RA) 
[Scholz et al. 1999, Wobus and Loeser 2011] was done. RA, a derivative of vitamin A 
and a central factor in embryonic development was found to influence the cardiac in vitro 
differentiation in a time- and concentration-dependent manner [van Laake et al. 2005, 
Gilbert 2006]. It has a crucial function in the embryonic development through regional 
patterning control, especially in the organogenesis of the heart, where it is involved in 
anteroposterior patterning and looping [Campo-Paysaa et al. 2008]. When not expressed 
in a temporally and spatially controlled manner, in physiologically high concentration for 
instance, RA instead acts as a teratogen hampering organogenesis of several organs [Lee 
et al. 2012]. Application of 5 nM RA throughout the differentiation period (described in 
Materna et al. 2013) showed an inhibition of cardiac differentiation similar to the one 
reported for example by Scholz et al. [1999], proving the validity of the assay as 
performed in the current work. 
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The formation of spontaneously contracting cardiomyocytes is one crucial endpoint of 
the assay. However, also other muscle types can develop in the in vitro cultures that show 
spontaneous contraction, such as skeletal myocytes [Dinsmore et al. 1996]. Hence, the 
formation of cardiomyocytes was, along with the spontaneous contraction proven 
regularly by Western Blot analysis and immunocytochemistry (see 3.1.3). The Western 
Blot analysis demonstrated the expression of cardiac troponin I throughout the observed 
period (days 10 to 30, Figure 3.3) in which contractions are visible. Cardiac troponin I is 
a regulatory protein controlling the calcium-mediated interaction between actin and 
myosin and it is only found in myocardium [Sharma et al. 2004]. The expression of it in 
cardiomyocytes derived from mESC is in accordance with Baharvand et al. [2006]. 
Cardiac troponin I was additionally detected by immunocytochemistry (Figure 3.2). The 
analysis of these samples revealed that the fractions of cardiomyocytes among all cells 
was found to be below 5% each. A percentage of cardiomyocytes differentiated from 
mESC of 3 to 5% has been reported in literature as well [Boheler et al. 2002]. The gene 
expression studies of other cardiac markers (discussed in 4.5.5) further confirm the 
formation of cardiomyocytes in the system used in this work. 
 
Conclusively, the assay as performed in the current work was successfully validated and 
thus used in subsequent radiation experiments. 
 
4.5 Influence of radiation on the differentiation 
 
4.5.1 Fraction of beating embryoid bodies 
 
As mentioned above, the spontaneous differentiation of ES-D3 into contracting 
cardiomyocytes was based on the EST. ES-D3 cells were irradiated in pluripotent culture, 
to mimic the exposure in the very early developmental stadium of the blastocyst. The 
differentiation assays were then performed at two different time-points, 0h and 72h after 
exposure of the cells with either carbon ions or x-rays (chapter 2.5). For the 0h 
experiments ES-D3 were differentiated immediately after exposure to examine the 
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influence of direct radiation damages, i.e. mainly cell death and cell inactivation but also 
altered gene expression. For the 72h experiments, exposed ES-D3 cells were allowed to 
grow further under pluripotent culture conditions. They were passaged 24h after exposure 
and differentiated 48h later, i.e. 72h after exposure. In the time frame of 72h, cells 
exposed to 2 Gy of carbon ions for example were found to have doubled around 3.7 times 
[Luft et al. 2013b, submitted]. In that way, even after a passage, the effects on the 
differentiation should be observed independent from cell death. The fraction of 
spontaneously beating EBs (i.e. containing contracting cardiomyocytes) was measured. 
Additionally, cell death, cell growth through EB size and proliferation in EBs were 
performed to complement the results. 
 
Consistent with the EST the influence of radiation on the formation of beating EBs was 
measured on day 10 of differentiation. Here, a clear LET-dependent inhibition was 
noticed, both for 0h and 72h experiments. High-LET carbon ions were about twice as 
effective as low-LET x-rays comparing iso-effective doses for the 0h experiments (figure 
3.10 and table 4.1). Interestingly, an RBE of about 3 was found for cell killing, also 
measured directly after radiation exposure (0h, figure 3.4 and table 4.1). This suggests a 
dependence of the inhibition to beating EBs on the cell inactivation and thus on the initial 
number of viable cells present in the EBs. For 72h experiments, the fraction of beating 
EBs there was not affected by x-rays, whereas for carbon ions there was still a dose-
dependent inhibition (figure 3.10). In the cell survival data, however, a slight decrease in 
the survival of cells irradiated with x-rays plated 72h after exposure is still measurable 
and carbon ions here were still three times as effective as x-rays (72h, figure 3.4 and table 
4.1). Probably there might be a threshold necessary to induce an effect, as x-rays 72h 
after exposure did not inhibit the fraction of beating EBs any more. To further confine 
that threshold, an experiment using a high dose of 10 Gy x-rays with differentiation 
directly after exposure was performed. Under these conditions EBs persisted not longer 
than day 3 of differentiation, i.e. besides a threshold for a measurable effect with this 
EST-like system, there is a lower limit in which cell killing concurrently hampers the 
formation of EBs. 
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Table 4.1 RBE values of carbon ions in comparison to x-rays for different endpoints. All effects 
where clear iso-effective doses were found were taken into account. Data originate from figures 
3.4, 3.10 and 3.15 (n.a.= not applicable for 72h experiments). 
0h 3 all
Survival
72h 3 all
Fraction of 0h ~2 0.5/1 and 3/6
beating Ebs
on day 10 72h n.a.
Size reduction 0h ~2 0.5/1 and 3/6
of embryoid
bodies 72h n.a.
Effect
Time point of 
cell processing 
after exposure
RBE
Iso-effective 
Doses (C-ions 
vs. x-rays) [Gy]
 
 
Interestingly, for EBs derived from cells exposed to 2 Gy x-rays and differentiated 72h 
after exposure the fraction of beating EBs was higher than in the control and all other 
doses, i.e. 0.5, 1, 3 and 6 Gy (figure 3.14). This effect was observed in all experiments 
(n=2), but only in one out of two the difference was statistically significant when 
compared to the control (Fisher’s exact test). A probable explanation for the elevated 
fraction of beating EBs is the production of reactive oxygen species (ROS). At the time 
of irradiation a burst of ROS is produced but is discussed to persist only less than a 
second. It is though under discussion whether radiation can perturb the balance of the 
natural ROS production leading to a long-term elevated level of ROS in the scale of days 
[Spitz et al. 2004, Buonanno et al. 2011]. On the other hand ROS were shown to enhance 
the differentiation into cardiomyocytes at a certain concentration [Sauer et al. 1999, 
Buggisch et al. 2007]. The conditions of an exposure to 2 Gy of x-rays and a subsequent 
differentiation 72h later might provide a ROS level necessary for the induction of an 
enhanced cardiomyogenesis. To prove this hypothesis, further experiments are necessary. 
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4.5.2 Initial cell number in embryoid bodies 
 
For the formation of beating EBs on day 10 of differentiation, the initial cell number at 
the time of the EB production and its reduction due to radiation exposure seems to be 
important. Furthermore, a threshold seems to exist for that effect. In agreement with this 
hypotheses are the data derived from the differentiation of EBs with different initial cell 
numbers irradiated with 2 Gy carbon ions and differentiated 72h after exposure (figure 
3.17). They clearly point at a threshold for cell inactivation after radiation necessary for 
an effect. The control with the reduced number of 500 cells showed no lower fraction of 
beating EBs on day 10 when compared to the control with 750 cells, i.e. the cell number 
of the standard protocol commonly used for all other experiments. When irradiated 
instead, both 750 cell EBs and 500 cell EBs exhibited a decreased beating fraction. The 
effect was more pronounced for 500 initially seeded cells. EBs made from 850 exposed 
cells did not show a decrease different from the normal condition control. The data 
indicate the threshold to be below 500 cells. That the cell number used to create the EB 
can influence the differentiation and its outcome has been reported in literature. 
Mansergh et al. [2009] found that for mESC a variation of the initial cell number changes 
the gene expression on day 4 of differentiation. Kurusowa [2007] states the rapid loss of 
any synchrony in differentiation for heterogeneously sized EBs. The direct influence on 
the cardiac differentiation for varying initial cell number in EBs was found as well and 
500 cells were shown insufficient to induce an effective cardiomyogenesis with mESC 
[Preda et al. 2013]. Ng et al. [2005] found that in hESC, the number of cells affected the 
hematopoietic differentiation, which is closely related to the cardiac differentiation 
[Gilbert 2006]. In the resulting EBs an efficient blood formation required more than 500 
cells. In the present study 500 cells were found to be able to induce an efficient cardiac 
differentiation. Taking into account inter-laboratory differences, the different species 
(mESC versus hESC) and all uncertainties, data from literature confirm a threshold close 
to 500 cells for an effective differentiation to cardiomyocytes. 
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4.5.3 Correlation of size and fraction of beating embryoid bodies 
 
The size of the EBs was measured on day 5 of differentiation directly after they were 
selected and transferred into the cavities of 24-well tissue culture plates. It was found that 
with an increasing dose of both carbon ions and x-rays, both for 0h and 72h 
differentiation experiments, the size of the EB was reduced. Carbon ions also here were 
found to be about twice as effective as x-rays (see table 4.1). Preda et al. [2013] also 
reported a direct correlation between the initial number of mESC in EBs and the size on 
day 4 of differentiation. This demonstrates again that the cell number in the EBs was 
altered by radiation induced cell killing in this work. Mansergh et al. [2009] found that 
EBs seeded with cell numbers from 500 to 1000 cells reach a size plateau at day 4 of 
differentiation. A direct correlation between the reduced size of the EBs and the resulting 
decline in the beating fraction was found in the present study (figures 3.15 and 3.16). 
This indicates that for the inhibition of the beating EB fraction, the threshold is around or 
below 500 cells, as in the case of the work no plateau but a decrease was found that was 
correlated with the effect and the dose. If size and initial cell number are related, and if 
the initial cell number influences the differentiation, consequently the size affects 
differentiation as well. This is further supported by the same RBE (about 2) of carbon 
ions for inhibiting the fraction of beating EBs and for reducing their size (see table 4.1). 
That size affects differentiation was already reported by Messana et al. [2008] who found 
implications of the EB size on chondrogenesis of differentiating ES-D3. Preda et al. 
[2013] and Choi et al. [2010] showed the dependence of cardiac differentiation on the 
size in mESC. Yet, in the 72h differentiation experiment, a significantly reduced EB size 
was found after exposure to 3 Gy x-rays but no decline in the fraction of beating EBs 
(figure 3.16). However, this measurement is derived from one experiment only and might 
therefore be considered an outlier. Deductively, so far the results instead indicate a 
correlation of EB size and initial cell number with the resulting effect. 
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4.5.4 Cell proliferation and apoptosis 
 
Measurements of proliferation and apoptosis of differentiating cells in the EBs were 
performed to further elucidate the role of the cell number in the differentiation assays. 
Proliferation was analysed by two different methods, i.e. by measuring EdU-positive cells 
with flow cytometry or analysis by fluorescence microscopy. EBs derived from a control 
and from a 3 Gy x-rays irradiated sample, differentiated immediately after exposure (0h), 
were analysed on day 5 of differentiation by both techniques (see chapter 3.3.3). No 
comparison with high-LET radiation is available here. Neither flow cytometry nor 
microscopic analysis showed a significant difference between the samples indicating that 
low-LET radiation damage did not persist until day 5 of differentiation. The data rather 
suggest that a crucial point for a radiation-induced effect is the initial cell number. 
Embryonic stem cell cultures contain a high fraction of S-phase cells (i.e. proliferating 
cells) and have a short G1-phase, progenitors and differentiating cells with ongoing 
lineage selection lower that fraction [White and Dalton 2005]. Further studies, especially 
kinetics in terms of EdU-uptake are needed to estimate the fraction of cells that is not yet 
differentiating in control or exposed samples. This may contribute to obtain further 
information on the delay in differentiation as discussed below. 
 
The influence of radiation on the cell death was investigated by analysing the 
morphology of the cell nuclei and a few data points were confirmed by the caspase-3 
activity assay. High-LET carbon ions were found to be generally more efficient in 
inducing apoptosis in pluripotent ES-D3 cultures than x-rays (figures 3.5 to 3.8). For cells 
reseeded directly after exposure (figures 3.5 and 3.6), only high doses (i.e. 3 Gy carbon 
ions, 6 and 10 Gy x-rays) elevated the apoptosis level already one day after exposure, 
while for the lower doses, cell death levels increased not before two days after exposure. 
This is in accordance with data from Rebuzzini et al. [2012] that showed an earlier onset 
in apoptosis for the mESC line R1 for 5 Gy γ-rays than for 2 Gy γ-rays. In general, data 
from the current work revealed a rise in apoptosis with dose for both high- and low-LET 
radiation when cells were reseeded directly after irradiation. A trend towards increasing 
cell death at higher doses of low LET γ-rays is reported also by Wilson et al. [2010] for 
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hESC. Cell death data for high LET radiation are not available in literature up to date. To 
investigate the influence of the passage (performed for the 72h differentiation 
experiments) on the persistence of cell death in pluripotent ES-D3, cells were reseeded 
also for apoptosis measurements (Figures 3.7 and 3.8). Due to the passage, the low doses 
applied here (i.e. 0.5 and 1 Gy carbon ions) showed apoptosis levels only slightly 
increased compared to control, whereas the higher doses still exhibited relatively high 
levels two and three days after exposure. Although being passaged, and thereby likely 
undergoing enhanced selection, ES-D3 cultures retained elevated cell death levels. This 
underlines the pronounced role of apoptosis, which is reported for mESC cultures. To 
avoid passing DNA damage to the progeny, mESC are discussed to facilitate a massive 
induction of cell death when compared to somatic cells [Hong and Stambrook 2004, 
Tichy 2011]. That might explain why an elevated level of apoptosis for high doses 
persists even after a passage. It is therefore remarkable that when measured in 
differentiating EBs, apoptosis was found to be affected by radiation only on day 1 after 
exposure in the 0h experiments (figures 3.18 and 3.19). Carbon ions here again were 
more effective than x-rays, concordantly with all other endpoints. However, for all later 
data points no cell death rate different from control was detected. The only exception, in 
which elevated cell death rates in EBs were detected beyond day 1 after exposure was the 
sample irradiated with 10 Gy x-rays (0h experiment, figure 3.19). However, these cells 
were not capable of forming stable EBs as they disaggregated after day 3 of 
differentiation, most likely due to the exacerbated damage. Radiation-induced cell death 
in the early EBs is consistent with the data discussed above. They confirm that radiation 
reduces the initial number used for EB formation due to cell killing and thus can affect 
the differentiation into beating cardiomyocytes. Interestingly, for 72h experiments, no 
significant persistent increase of apoptosis levels was found after exposure to both 
radiation qualities (figures 3.20 and 3.21). However the passage did not remove apoptotic 
cells from the culture and differentiation was still affected in the case of carbon ions. The 
slight increase of cell death for x-rays (figure 3.21) must be valuated carefully due to its 
poor statistics, especially as no influence on the differentiation was found here. The 
discrepancy in the persistence of radiation-induced apoptosis between pluripotent ES-D3 
cultures and differentiating EBs has to be evaluated also in the context of the two 
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different cultures conditions, i.e. mainly with or without LIF and the EB as a 3D 
structure. Additionally, the reason that radiation-induced cell death was detectable only 
on day 1 after exposure might be explained with a high background level of apoptosis in 
the EBs probably impeding the distinction of the radiation-induced fraction. Two 
hypotheses can be discussed in the context of a high background level of apoptosis. 
Firstly, a limitation of nutrient and oxygen supply due to a gradient influencing the 
viability of the cells in the center of the EB might occur. However, EBs are thought to be 
loosely packed [Mansergh et al. 2009] and therefore should not suffer this phenomenon. 
Furthermore, Gassmann et al. [1996] showed that under norm-oxic (20%) culture 
conditions, the EBs’ core regions were sufficiently oxygenated. Another supply 
constriction could result from the limited volume of medium in the hanging drop, in 
which the EBs stay until day 3 of differentiation. However, subsequently they are 
transferred in suspension culture and in most cases apoptosis levels remained similar on 
days 3 and 5 of differentiation. Increased background apoptosis due to limitations is 
therefore unlikely. 
Secondly, apoptosis is known to play a crucial role in the embryonic development [Miura 
2011]. It was shown that in EBs from ES-D3, inner cells undergo apoptosis and thereby 
contribute to the process of cavitation, resembling the embryonic yolk sac formation. 
Apoptosis is therefore pivotal in EBs for advanced morphogenesis [Karbanová and 
Mokrý 2002]. Hence, the high background level of cell death in EBs is very likely due to 
the mentioned developmental processes. 
 
In summary, data for proliferation and apoptosis in EBs suggest that radiation mainly 
affects the initial cell number in the first days of the differentiation. Hence, they indicate 
that radiation is primarily influencing differentiation by reducing the cell number in the 
EBs. 
 
4.5.5 Time-course of cardiac differentiation 
 
The fractions of beating EBs on day 10 of differentiation were shown to be decreased by 
radiation in a dose-dependant manner, most likely due to cell killing in the early EB as 
Discussion 
 88 
discussed above. However, cardiac differentiation continued over time resulting in a 
delayed emergence of spontaneously contracting EBs (figures 3.11 to 3.14). Over the 
differentiation time-course all cumulative fractions of beating EBs approached the control 
levels. The cumulative fractions of the controls themselves increased in the time-course 
and reached 100% at the end in most cases. This is in line with findings of others that 
reported a rise in the number of spontaneously beating foci with time so that finally all 
EBs were contracting [Boheler et al. 2002]. The RBE of carbon ions for inhibiting the 
development of beating EBs on day 10 was about 2. Iso-effective doses of carbon ions 
and x-rays also showed a similar behaviour in developmental kinetics of beating 
cardiomyocytes pointing to the hypothesis that the origin of the lower fraction of beating 
EBs for both samples is the same, i.e. the reduction in cell number due to radiation. 
 
Over the observed time-course of differentiation the expression of cardiac marker genes 
was measured on the basis of one experiment with EBs differentiated immediately (0h) 
after exposure to 3 Gy of carbon ions or 3 of Gy x-rays (figure 3.24). The cardiac 
markers used comprised proteins related to function in embryonic cardiomyocytes. Thus, 
cardiac α-actin (cAct) is the main actin isoform in the heart and the major component in 
the myofibrils in the cardiac muscle where it is involved in contraction [Kumar et al. 
1997, Rai et al. 2008]. β-myosin heavy chain (β-Myh, also termed Myh7) is one of the 
isoforms of the myosin heavy chains that mediate muscle contraction in the mammalian 
heart. Myh7 is the predominating isoform in cardiomyocytes of a developing heart 
[Tardiff et al. 2000, Quiat et al. 2011]. Cardiac troponin T (cTropT2) is a cytoskeletal 
regulatory protein involved in cardiomyocyte contraction by controlling the calcium 
mediated interaction between actin and myosin [Sharma et al. 2004, Mobley et al. 2010]. 
The hyperpolarisation-activated, cyclic nucleotide-gated channel (Hcn4) is a part of the 
pacemaker current If and is mostly expressed in cardiomyocytes of the pacemaker 
regions, i.e. the sinoatrial node [Stieber et al. 2003, Chen et al. 2010]. It is essential for 
heart impulse generation and conduction [Baruscotti et al. 2011]. Finally, Gata4 is an 
early cardiac marker as it is expressed from the first cardiac lineages on and it remains 
expressed over the time of cardiomyocyte specification up to adulthood. In all stages, it 
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plays an important role as key regulator for gene expression and cellular activity and has 
a pivotal contribution to heart lineage differentiation [Molkentin 2000, Zhou et al. 2012]. 
Generally, an increase in the gene expression of cardiac markers was found until day 10. 
For the control sample, later on the expression levels of cAct, Myh7 and cTropT2 tended 
to decrease. As the cumulative fraction of beating EBs also for controls increased with 
continued differentiation (discussed above), the reason is most likely not a loss of 
cardiomyocytes with time, but the continued growth of other cell types in the expanding 
EBs. Differentiated cardiomyocytes in the contractile focis of EBs can cease beating or 
slow down beating rate over time but remain viable in culture [Boheler et al. 2002]. As 
the three mentioned markers are not only structural proteins but also involved in the 
contractile function, another reason for their expressional decline could be the ceased 
contraction, that beating clusters typically showed after several days in culture. However, 
these transcripts remained expressed over the differentiation time-course which is in 
accordance with literature [Rohwedel et al. 2001, Boheler et al. 2002, Wei et al. 2005]. 
Hcn4 expression after day 10 tended to increase in the control, indicating a specification 
of embryonic cardiomyocytes as it is a marker for pacemaker activity. Its function and 
abundance in mESC derived cardiomyocytes was reported [Boheler et al. 2002, Wei et al. 
2005]. The reason for the decline in the later differentiation days of the carbon ion 
exposed sample remains to be elucidated and needs to be confirmed by further 
experiments. Gata4 in the control sample maintained the level of gene expression which 
is in accordance with its multiple functions not only in development but also in 
differentiation and cardiomyocyte function. An early and continued expression over 
differentiation is reported in literature [Boheler et al. 2002, Wei et al. 2005]. Generally, 
for exposed samples a delayed pattern of expression was found when compared to the 
controls. This delay is more pronounced for the sample exposed to carbon ions than for 
the one exposed to for x-rays that tends to reach levels similar to the control more often 
and earlier for the different genes. Given the findings discussed above, where a delay in 
the differentiation into beating cardiomyocytes was found, the delay in the gene 
expression correlates with that. Hence, data from the gene expression study can be 
interpreted in two ways. Firstly, one can hypothesise that radiation perturbed the gene 
expression pattern per se and that the initial lowered fractions of beating EBs and the 
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subsequent delayed increase over time-course is due to the altered expression of genes 
involved in cardiac development. Radiation indeed was shown to alter the gene 
expression [e.g. Ding et al. 2005] in somatic cells. However, another assumption is more 
likely. The data obtained in the current work point to the cell number hypothesis. If there 
is indeed a threshold of the cell number initially needed in an EB for an efficient cardiac 
differentiation, this can explain the delayed expression of cardiac genes. The EBs then 
might need more time to gain a sufficient number of cells to start an efficient cardiac 
differentiation. The resulting delay when compared to unexposed EBs is then seen in the 
expression of genes related to cardiac differentiation. The delayed increase of 
differentiation-associated genes is consistent with the analysis of pluripotency-associated 
genes expression as discussed above, where a delay in their decline was found. However, 
data obtained in the current work or gene expression in general have to be valued 
carefully as they are derived from one experiment only. 
 
A mathematical model was developed in order to justify the cell number hypothesis. The 
model reflects the contribution of the cell number, the counteracting cell killing and the 
probability that EBs start beating. The modelled data were not in agreement with the 
experimentally obtained data. Thus, the model does not support the cell number 
hypothesis. However, at the same time it did not indicate a disproof of that hypothesis. 
The discrepancy between modelled and measured data might be explained with some 
weak points of the model. Firstly, the data used for the growth rate τ in the equation are 
derived from pluripotent ES-D3. As mentioned above, mESC have short G1 phases and 
cultures contain a high percentage of S-phase cells. Their population doubling time is 
short. With beginning and ongoing differentiation the percentage of pluripotent cells in 
the EBs decreases continuously and hence the cell cycle distribution changes [White and 
Dalton 2005], accompanied by a change in the population doubling time. The dynamic 
changes of it are difficult to estimate and are not reflected in the current model. Being a 
simplified model, the doubling time of pluripotent ES-D3 was chosen as an 
approximation. Furthermore, the fitting to find the proper parameters for the model was 
performed using mean values of the controls. Controls, however, as the model is based on 
the influence of cell number reduced by cell killing represent extreme values in that 
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context, as they have a high fraction of beating EBs already from day 10 on that increases 
only slightly with time. This affects the robustness of the parameters that were 
subsequently used to reproduce all curves with the model. 
 
4.6 Future perspectives 
 
The hypothesis inferred from these results, whereby the cell number reduction may be the 
determining effect for the delay in cardiac differentiation has to be confirmed in further 
experiments. The results point to that hypothesis, however, another effect of radiation 
cannot be excluded. The aspect of a threshold for the cell number in EBs to induce an 
effect as suggested by the data presented needs to be confined to disentangle the cell 
number influence from other radiation-mediated influences. 
 
Furthermore, given the broad spectrum of cells, which can be derived from the in vitro 
differentiation of mESC [Keller 2005], other aspects of the influence of radiation on the 
embryonic development can be studied. However, mESC lines, such as ES-D3 and R1 
tend to accumulate chromosomal aberrations, both numerical and structural, during in 
vitro culture that might influence their differentiation capacity [Luft diploma thesis 2011, 
Rebuzzini et al. 2012 Luft et al. 2013b submitted]. Indeed, for the validated EST, cells 
should be used only until an accumulated passage number of 25 as cultures older than 
that lead to inconsistent differentiation [Seiler and Spielmann 2011]. Data from our lab 
suggest that hESC instead are genetically more stable with continued differentiation 
[Luft, unpublished data]. Furthermore, derived from the same species, hESC are more 
relevant for radiation risk studies on development than mESC are. In vitro differentiation 
of hESC into cardiomyocytes is established [Wobus and Loeser 2011] and its potential 
for radiation risk assessment exceeds embryonic development. Cardiomyocytes 
differentiated from hESC may serve as a model to study adverse cardiac effects of 
radiation, a further topic of interest in radiation therapy. Data published by Azimzadeh et 
al. [2011] suggest that the heart reacts with fast structural and functional changes to 
ionising radiation that might be transformed in long-term damage. Radiation-induced 
cardiovascular damage and subsequent adverse effects, mostly in patients that received 
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radiotherapy have been reported and remain a concern especially for conventional 
radiotherapy, whereas particle therapy might be an alternative to minimise cardiac side-
effects [Adams et al. 2003, Wittig et al. 2011]. Furthermore, particle therapy is discussed 
as a tool for radiosurgery also in the heart [Bert et al. 2012]. It is therefore necessary to 
improve the risk estimation of radiation therapy on the heart and functional 
cardiomyocytes derived from hESC may provide a useful tool in that context. 
However, ethical objections and restrictive legislation limit the application of in vitro 
differentiation of hESC [Bundesministerium der Justiz - StZG 2002, Leist et al. 2008]. 
Furthermore, differentiation of hESC into cardiomyocytes is more complex due to the 
requirement of growth factors and hence more expensive than for mESC [Wobus and 
Loeser 2011]. Additional limitation is imposed on by the low efficiency of cardiac 
differentiation below 1% when compared to mESC [Murry and Keller 2008], although 
effort is done to improve the efficiency [e.g. Fonoudi et al. 2013]. Hence, the in vitro 
differentiation of mESC remains an alternative for risk assessment studies in the 
mentioned fields. 
 
4.7 Conclusions 
 
The question the current work is based upon is whether radiation affects the early cardiac 
development and whether high-LET carbon ions differ in inducing a putative effect when 
compared to low-LET x-rays. Using the EST-like assay, it was found that radiation 
inhibited the formation of spontaneously contracting cardiomyocytes in EBs and that 
high-LET radiation was more effective. A first clue that the radiation influence might be 
related to cell inactivation and consequently to a reduced initial cell number in the EBs 
was provided by the data from the survival curves. Those are in accordance concerning 
the RBE of carbon ions for the inhibition of the beating EB fraction and the attenuation of 
same when cells were differentiated 72h after exposure. The elevated radiation-induced 
apoptosis in ES-D3 until the moment of differentiation and the reduced size of the EBs, 
correlated with the dose-effect curves underpin the cell number hypothesis. Furthermore, 
the differentiation assay with various initial cell numbers strengthens that hypothesis and 
additionally suggests a threshold to which the cell number has to be reduced to measure 
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an effect. The delay in the cardiac differentiation, as seen over the differentiation period 
both in the cumulative fractions of beating EBs and in the gene expression of cardiac 
markers further supports the hypothesis of the initial cell number. Furthermore for all 
endpoints, high LET carbon ions were shown to be more effective than x-rays. 
EBs resemble the early embryo and their in vitro differentiation thus the early embryonic 
development. Hence, the assumption of the dependence of the cardiac in vitro 
differentiation on a certain cell number necessary might be valid for the early embryonic 
development in general. Data on the influence of ionising radiation on the early 
development (pre-implantation stage) point to lethality as the dominating effect. This is 
mainly assumed from experiments where mice zygotes or blastomeres were exposed 
[ICRP 2003]. The cells used in this work resemble the blastocyst stage, i.e. the latest 
stage of the pre-implantation phase and thus the results obtained in the current work 
contribute to a better understanding of radiation effects on the pre-implantation embryo. 
The data indicate that cells of the blastocyst are damaged by radiation and that the 
consequence is a delayed development rather than lethality. In that early stage, damaged 
cells probably are eliminated from the pool to allow correct development and undamaged 
cells or cells with repaired damage might compensate the cell loss [ICRP 2003, 
Rebuzzini et al. 2012]. Indeed, ESC are discussed to possess efficient DNA repair 
mechanisms and the induction of apoptosis following DNA damage is significantly 
higher than in differentiated cells [Denissova et al. 2012, Nagaria et al. 2012]. The 
hypothesis of a minimum number of cells needed for normal development and the time 
required to compensate cell loss thus might explain a developmental delay of the pre-
implantation embryo. 
Apart from the appropriate blastocyst development, a timely regulated expression of 
embryonic growth factors and cytokines, controlled by a complex network of different 
factors is prerequisite for an efficient implantation [Singh et al. 2011b]. In the menstrual 
cycle, however, there is only a limited implantation time span of a few days, to which the 
blastocyst is restricted for an interaction with the endometrium of the uterus [Teklenburg 
et al. 2010]. A radiation-induced delay in development may perturb that intricate 
signalling and thus prevent the embryo from a proper implantation in the narrow time 
frame, leading to a pregnancy loss. In that context, high-LET radiation, as it is more 
Discussion 
 94 
efficient in cell killing would comprise a higher risk for the blastocyst-stage embryo than 
low-LET radiation does. 
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Appendix 
 
A Tables 
 
Table A.1 Additional information to figure 3.6. Cell death measured in cells immediately 
reseeded after exposure to x-rays. 
Dose Days after Mean Value Error Error Type Number of
[Gy] Expsoure [%] [%] Experiments
0 1 2,58 0,16 SEM 3
1 2,73 0,94 SEM 2
3 3,91 1,28 SEM 2
6 7,00 0,82 Poisson 1
10 18,36 1,21 Poisson 1
0 2 4,49 1,27 SEM 3
1 8,68 0,84 SEM 2
3 15,03 7,25 SEM 2
6 15,77 1,15 Poisson 1
10 38,11 2,05 Poisson 1
0 3 13,65 3,56 SEM 3
1 15,44 1,11 SEM 2
3 13,13 1,87 SEM 2
6 18,62 1,27 Poisson 1
 
 
Table A.2 Additional information to figure 3.7. Cell death after exposure to carbon ions. 
Dose Days after Mean Value Error Error Type Number of
[Gy] Expsoure [%] [%] Experiments
0 2 2,04 0,29 SEM 3
0.5 2,80 0,82 SEM 3
1 3,18 0,56 SEM 2
2 7,86 1,45 SEM 3
3 11,13 2,49 SEM 3
0 3 2,14 0,77 SEM 3
0.5 3,30 0,62 SEM 3
1 2,74 0,50 Poisson 1
2 8,26 5,41 SEM 2
3 14,76 1,27 SEM 2
0 4 7,57 0,82 Poisson 1
0.5 10,27 0,88 Poisson 1
2 6,34 0,75 Poisson 1
3 7,29 0,76 Poisson 1
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Table A.3 Additional information to figure 3.10. Dose-effect curves of carbon ions and x-rays on 
the development of spontaneously contracting cardiomyocytes. 
Dose Radiation Plating after Fraction of Error Error Type Number of
[Gy] exposure [h] beating EB Experiments
1 x-rays 0 0,74 0,08 SEM 2
3 0,35 0,06 SEM 2
6 0,01 0,01 Bernoulli 1
0.5 72 1,02 0,06 SEM 3
1 0,98 0,12 SEM 2
2 1,15 0,05 SEM 3
3 1,04 0,13 SEM 3
6 1,06 0,06 Bernoulli 1
0.5 carbon ions 0 0,80 0,15 SEM 2
3 0,04 0,04 SEM 2
0.5 72 0,79 0,18 SEM 3
1 0,60 0,17 SEM 2
2 0,61 0,28 SEM 2
3 0,37 0,08 SEM 3
 
 
 
Table A.4 Additional information to figure 3.11. Cumulative fraction of beating embryoid bodies 
differentiated 0h after exposure to carbon ions. 
Dose Days of Fraction of Error Error Type Number of
[Gy] Different. beating EB Experiments
0 10 0,96 0,04 SEM 2
0.5 0,77 0,15 SEM 2
3 0,04 0,04 SEM 2
0 15 0,99 0,01 SEM 2
0.5 0,89 0,11 SEM 2
3 0,25 0,10 SEM 2
0 21 0,99 0,01 SEM 2
0.5 0,92 0,08 SEM 2
3 0,51 0,07 SEM 2
0 25 1,00 0,00 Bernoull i 1
0.5 0,88 0,05 Bernoull i 1
3 0,65 0,07 Bernoull i 1
0 30 1,00 0,00 Bernoull i 1
0.5 0,94 0,03 Bernoull i 1
3 0,79 0,06 Bernoull i 1
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Table A.5 Additional information to figure 3.12. Cumulative fraction of beating embryoid bodies 
differentiated 0h after exposure to x-rays. 
Dose Days of Fraction of Error Error Type Number of
[Gy] Different. beating EB Experiments
0 10 0,99 0,01 SEM 3
1 0,73 0,08 SEM 2
3 0,35 0,06 SEM 2
6 0,01 0,01 Bernoull i 1
0 15 0,99 0,01 SEM 3
1 0,86 0,05 SEM 2
3 0,48 0,15 SEM 2
6 0,07 0,03 Bernoull i 1
0 21 0,99 0,01 SEM 3
1 0,91 0,03 SEM 2
3 0,66 0,09 SEM 2
6 0,60 0,05 Bernoull i 1
0 25 0,99 0,01 SEM 2
1 0,88 0,05 Bernoull i 1
3 0,78 0,10 SEM 2
6 0,81 0,04 SEM 2
0 30 0,99 0,01 SEM 2
1 0,96 0,03 Bernoull i 1
3 0,80 0,10 SEM 2
6 0,90 0,03 Bernoull i 1
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Table A.6 Additional information to figure 3.13. Cumulative fraction of beating embryoid bodies 
differentiated 72h after exposure to carbon ions. 
Dose Days of Fraction of Error Error Type Number of
[Gy] Different. beating EB Experiments
0 10 0,87 0,07 SEM 3
0.5 0,69 0,16 SEM 3
1 0,52 0,15 SEM 2
2 0,53 0,24 SEM 2
3 0,32 0,07 SEM 3
0 11 0,85 0,08 SEM 2
0.5 0,58 0,02 SEM 2
1 0,59 0,16 SEM 2
2 0,61 0,22 SEM 2
3 0,30 0,09 SEM 2
0 13 0,87 0,06 SEM 2
0.5 0,66 0,07 SEM 2
1 0,66 0,18 SEM 2
2 0,65 0,25 SEM 2
3 0,36 0,14 SEM 2
0 15 0,93 0,05 SEM 3
0.5 0,83 0,13 SEM 3
1 0,70 0,18 SEM 2
2 0,69 0,23 SEM 2
3 0,49 0,13 SEM 3
0 17 0,94 0,02 SEM 2
0.5 0,80 0,11 SEM 2
1 0,76 0,14 SEM 2
2 0,76 0,18 SEM 2
3 0,48 0,21 SEM 2
0 19 0,95 0,03 SEM 2
0.5 0,89 0,05 SEM 2
1 0,81 0,10 SEM 2
2 0,83 0,10 SEM 2
3 0,57 0,18 SEM 2
0 21 0,97 0,02 SEM 3
0.5 0,92 0,05 SEM 3
1 0,84 0,07 SEM 2
2 0,89 0,07 SEM 2
3 0,73 0,07 SEM 3
0 25 1,00 0,00 Bernoull i 1
0.5 1,00 0,00 Bernoull i 1
3 0,82 0,04 Bernoull i 1
0 30 1,00 0,00 Bernoull i 1
0.5 1,00 0,00 Bernoull i 1
3 0,89 0,03 Bernoull i 1
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Table A.7 Additional information to figure 3.14. Cumulative fraction of beating embryoid bodies 
differentiated 72h after exposure to x-rays. 
Dose Days of Fraction of Error Error Type Number of
[Gy] Different. beating EB Experiments
0 10 0,81 0,12 SEM 3
0.5 0,81 0,08 SEM 2
1 0,78 0,09 SEM 2
2 0,91 0,07 SEM 2
3 0,83 0,10 SEM 3
6 0,85 0,05 Bernoull i 1
0 11 0,77 0,13 SEM 2
0.5 0,85 0,06 SEM 2
1 0,81 0,08 SEM 2
2 0,97 0,01 SEM 2
3 0,84 0,14 SEM 2
0 13 0,83 0,08 SEM 2
0.5 0,89 0,03 SEM 2
1 0,86 0,03 SEM 2
2 0,98 0,02 SEM 2
3 0,86 0,11 SEM 2
0 15 0,90 0,06 SEM 3
0.5 0,90 0,04 SEM 2
1 0,86 0,03 SEM 2
2 0,98 0,02 SEM 2
3 0,92 0,07 SEM 3
6 0,92 0,04 Bernoull i 1
0 17 0,86 0,05 SEM 2
0.5 0,90 0,04 SEM 2
1 0,86 0,03 SEM 2
2 0,98 0,02 SEM 2
3 0,92 0,06 SEM 2
0 19 0,86 0,05 SEM 2
0.5 0,93 0,01 SEM 2
1 0,89 0,01 SEM 2
2 0,98 0,02 SEM 2
3 0,94 0,04 SEM 2
0 21 0,91 0,05 SEM 3
0.5 0,93 0,01 SEM 2
1 0,89 0,01 SEM 2
2 0,98 0,02 SEM 2
3 0,96 0,03 SEM 3
6 0,94 0,03 Bernoull i 1
0 25 1,00 0,00 Bernoull i 1
3 1,00 0,00 Bernoull i 1
0 30 1,00 0,00 Bernoull i 1
3 1,00 0,00 Bernoull i 1
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Table A.8 Additional information to figure 3.15. Size of embryoid bodies and fraction of beating 
embryoid bodies after exposure to carbon ions and x-rays (differentiation initiation at 0h). 
Dose Radiation Size of EB Error Error Type Number of
[Gy] Experiments
0 carbon ions 11,31 0,74 SEM 2
0.5 9,35 2,37 SEM 2
3 3,68 0,06 SEM 2
0 x-rays 12,42 1,04 SEM 2
1 10,39 0,87 SEM 2
3 7,55 2,47 SEM 2
6 3,66 1,44 SD 1
 
 
 
Table A.9 Additional information to figure 3.16. Size and beating fraction of embryoid bodies 
after exposure to carbon ions and x-rays (differentiation initiation at 72h). 
Dose Radiation Size of EB Error Error Type Number of
[Gy] Experiments
0 carbon ions 14,11 1,67 SEM 3
0.5 9,00 1,80 SEM 3
1 8,14 1,30 SEM 2
2 6,62 0,31 SEM 2
3 5,20 0,32 SEM 3
0 x-rays 13,96 3,36 SD 1
3 7,84 1,66 SD 1
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Table A.10 Additional information to figure 3.17. Relationship between initial cell number and 
fraction of beating embryoid bodies after exposure to carbon ions (differentiation initiation at 
72h). 
Dose Days of Cell Fraction of Error Error Type Number of
[Gy] Different. number beating EB Experiments
0 10 500 0,88 0,07 Bernoulli 1
750 0,87 0,07 SEM 3
850 0,79 0,08 Bernoulli 1
11 500 0,88 0,07 Bernoulli 1
750 0,85 0,08 SEM 2
850 0,79 0,08 Bernoulli 1
13 500 0,88 0,07 Bernoulli 1
750 0,87 0,06 SEM 2
850 0,92 0,06 Bernoulli 1
15 500 0,88 0,07 Bernoulli 1
750 0,93 0,05 SEM 3
850 0,92 0,06 Bernoulli 1
17 500 0,88 0,07 Bernoulli 1
750 0,94 0,02 SEM 2
850 0,92 0,06 Bernoulli 1
19 500 0,92 0,06 Bernoulli 1
750 0,95 0,03 SEM 2
850 0,92 0,06 Bernoulli 1
21 500 0,92 0,06 Bernoulli 1
750 0,97 0,02 SEM 3
850 0,96 0,04 Bernoulli 1
2 10 500 0,42 0,10 Bernoulli 1
750 0,53 0,24 SEM 2
850 0,83 0,08 Bernoulli 1
11 500 0,50 0,10 Bernoulli 1
750 0,61 0,22 SEM 2
850 0,83 0,08 Bernoulli 1
13 500 0,54 0,10 Bernoulli 1
750 0,65 0,25 SEM 2
850 0,87 0,07 Bernoulli 1
15 500 0,54 0,10 Bernoulli 1
750 0,69 0,23 SEM 2
850 0,87 0,07 Bernoulli 1
17 500 0,58 0,10 Bernoulli 1
750 0,76 0,18 SEM 2
850 0,87 0,07 Bernoulli 1
19 500 0,63 0,10 Bernoulli 1
750 0,83 0,10 SEM 2
850 0,87 0,07 Bernoulli 1
21 500 0,67 0,10 Bernoulli 1
750 0,89 0,07 SEM 2
850 0,91 0,06 Bernoulli 1
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Table A.11 Additional information to figure 3.19. Cell death in embryoid bodies after exposure to 
x-rays, 0h experiments. 
Dose Days after Mean Value Error Error Type Number of
[Gy] Expsoure [%] [%] Experiments
0 1 13,13 0,72 SEM 3
1 17,34 1,61 SEM 2
3 19,17 6,57 SEM 2
6 35,90 1,88 Poisson 1
10 48,15 2,29 Poisson 1
0 3 39,07 15,25 SEM 3
1 27,62 1,61 SEM 2
3 31,35 2,35 SEM 2
6 37,89 1,89 Poisson 1
10 76,24 2,78 Poisson 1
0 5 35,52 4,51 SEM 3
1 43,82 18,91 SEM 2
3 48,35 22,53 SEM 2
6 22,39 1,39 Poisson 1
 
 
 
Table A.12 Additional information to figure 3.20. Cell death in embryoid bodies after exposure to 
carbon ions, 72h experiments. 
Dose Days after Days of Mean Value Error Error Type Number of
[Gy] Expsoure Different. [%] [%] Experiments
0 4 1 10,95 1,87 SEM 3
0.5 15,11 1,05 Poisson 1
2 13,23 2,26 SEM 3
3 9,51 0,96 Poisson 1
0 6 3 38,31 3,32 SEM 3
0.5 38,45 1,94 Poisson 1
2 38,48 1,45 SEM 3
3 39,77 1,81 Poisson 1
0 8 5 41,97 1,80 Poisson 1
0.5 25,25 1,40 Poisson 1
2 34,44 1,76 Poisson 1
3 42,36 2,05 Poisson 1
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B List of abbreviations 
 
BMP   Bone morphogenetic protein 
BSA   Bovine serum albumin 
cAct   Cardiac α-actin 
CCD (camera) Charged coupled device 
CT   Computed tomography 
cTrop-I  Cardiac troponin I 
cTropT2  Cardiac troponin T 
DAPI   4',6-diamidino-2-phenylindole 
DDR   DNA damage response 
DMSO  Dimethyl sulfoxide 
DSB   Double strand break 
EBs    Embroyid bodies 
ECC   Embryonic carcinoma cell 
ECL   Enhanced chemiluminscence 
ECVAM  European Centre for the Validation of Alternative Methods 
EDTA   Ethylenediaminetetraacetic acid 
EdU   5-ethynyl-2’-deoxyuridine 
EMT   Epithelial-to-mesenchymal transition 
EPI   Epiblast 
ESC   Embryonic stem cell 
EST   Embryonic stem cell test 
FCS   Foetal calf serum 
FGF   Fibroblast growth factor 
FITC   Fluorescein isothiocyanate 
FSC   Forward scatter 
Gapdh   Glyceraldehyde 3-phosphate dehydrogenase 
Hcn4   Hyperpolarisation-activated, cyclic nucleotide-gated channel 
hESC   Human embryonic stem cell 
HR   Homologues Recombination 
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HRP   Horseradish Peroxidase 
ICM   Inner Cell Mass 
ICRP   International Commission on Radiological Protection 
ICRU   International Commission on Radiation Units 
LET   Linear energy transfer 
LIF   Leakaemia inhibitory factor 
MEF   Mouse embryonic fibroblast 
mESC   Mouse embryonic stem cell 
Myh7   Myosin Heavy Chain-β 
NHEJ   Non-homologues end joining 
Oct-3/4  Octamer binding transcription factor)-3/4 
PE   Plating Efficiency 
PE   Primitive Endoderm 
PGC   Primordial Germ Cells 
RBE   Relative Biological Effectiveness 
REACH Registration, Evaluation, Authorisation and Restriction of 
Chemicals 
ROS Reactive Oxygen Species 
SIS18   Schwerionensynchrotron (Heavy Ion Synchrotron) 
SOBP   Spread Out Bragg-Peak (also: extended Bragg-Peak) 
Sox2   SRY-box 2 
SSBR   Single-strand Break Repair 
SSC   Side scatter 
StZG   Stammzellgesetz (German Stem Cell Act) 
TE solution  Trypsin-EDTA solution 
TE   Trophectoderm 
TGFβ   Transforming growth factor β 
ZGA   Zygote Genome Activation 
β-Myh Myosin Heavy Chain-β 
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C List of materials 
 
C.1 Chemicals 
 
Acetic acid (Merck) 
Acetone (LS Labor Service GmbH) 
Acrylamide (SIGMA Aldrich) 
APS (SIGMA Aldrich) 
BSA (SIGMA Aldrich) 
CASYTON solution (Schaerfe System) 
DAPI (Serva) 
DMEM, FG0435 (BIOCHROM AG) 
DMSO (Roth) 
ECL-Plus (Pierce) 
EDTA (Roth) 
Ethanol (AppliChem) 
Formaldehyde 37% (Merck) 
Gelatine (Merck) 
Glycine (AppliChem) 
Hoechst 33 342 (SIGMA Aldrich) 
Leukaemia inhibitory factor, ESGRO (Millipore) 
Methanol (Merck) 
Methyleneblue solution, Loeffler (Merck) 
Na3VO4 (SIGMA Aldrich) 
NaCl (SIGMA Aldrich) 
NaF (AppliChem) 
NEAA (BIOCHROM AG) 
NP-40 (SIGMA Aldrich) 
PBS-/- Dulbecco, w/o calcium and magnesium (BIOCHROM) 
Penicillin/Streptomycin (BIOCHROM AG) 
PMSF (AppliChem) 
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Potassium hydroxide (Merck) 
Protease Inhibitor Cocktail, Complete (Roche) 
SDS (AppliChem) 
TEMED (AppliChem) 
Tris-HCl (AppliChem) 
Triton-X-100 (Merck) 
Tween 20 (SIGMA Aldrich) 
VectaShield Antifade (Vector Laboratories) 
 
C.2 Solutions, buffers and gels 
 
β-mercaptoethanol working solution 
 5 ml PBS-/- 
 3.5 µl β-Mercaptoethanol 
 
BSA solution 
 0.4% BSA in PBS-/- 
 1% BSA in PBS-/- 
 
DAPI solution 
 100 µg/ml DAPI in PBS-/- 
 1 µg/ml DAPI in PBS-/- 
0.1 µg/ml DAPI in PBS-/- 
 
Hoechst 33 342 solution 
 10 µg/ml Hoechst 33 342 in PBS-/- 
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3x Loeffler’s Methyleneblue solution 
 30% Methyleneblue 
 9% Potassium hydroxide solution (0.1%) 
 5% Methanol 
 in ultrapure water 
Paraformaldehyde solution 
(3.7% in PBS-/-) 
 
RIPA buffer 
 50 mM Tris-HCl [pH 7.4] 
 150 mM NaCl 
 1% NP-40 
 0.25% Triton-X-100 
 1 mM EDTA 
 1 mM PMSF 
 1 mM Na3VO4 
 1 mM NaF 
 1x Protease Inhibitor Cocktail 
 
SDS-PAGE gel 
 3.9% Tris-HCl [pH 8.8] 
 0.1% SDS 
 12% Acrylamide 
 0.04% TEMED 
 0.1% APS 
 in ultrapure water 
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SDS running buffer 
 40 mM Glycine 
 120 mM Tris-HCl 
 0.1% SDS 
 in ultrapure water 
 
TBST 
 20 mM Tris-HCl [pH 7.5] 
 500 mM NaCl 
 0.05% Tween 20 
 in ultrapure water 
 
TE solution        PAN Biotech 
 0.05%  Trypsin 
 0.02%  EDTA 
 
Transfer buffer 
 192mM Glycine 
 25mM Tris-HCl 
 0.1% SDS 
 20% Methanol 
 in ultrapure water 
 
Triton-X-100 solution 
 0.5% Triton-X-100 in PBS-/- 
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C.3 Cell culture media 
 
Complete medium 
500 ml  DMEM 
90 ml   FCS (serum A, heat-inactivated) 
5 ml   NEAA 
5 ml   L-glutamine 
5 ml   Penicillin and streptomycin 
6.1 ml  β-Mercaptoethanol working solution 
 
Cryo medium 
13 ml  Complete Medium 
5 ml  FCS (serum A, heat-inactivated) 
2 ml  DMSO 
 
C.4 Tested sera 
 
Serum A: Biochrom AG, catalogue number: S 0115, LOT number: 0565 L 
Serum B: Biochrom AG, catalogue number: S 0613 / S 0615, LOT number: 0892 T 
Serum C: Biochrom AG, catalogue number: S 0613 / S 0615, LOT number: 0397 L 
 
C.5 Consumables 
 
15 ml tube (TPP) 
24-well tissue culture plates (BIOCHROM AG) 
50 ml tube (Greiner) 
96-well Fast Thermal Cycling Plates (Life Technologies) 
Cell counter vials (Schaerfe System) 
Cell scraper (TPP) 
Chamber slides, 2 chambers (Nalge Nunc International) 
Cover slip, 24 x 46 mm (Roth) 
Cryo vials, Cellstar CryoS (Greiner) 
Appendix 
 110
ECL Film, Amersham HyperflimTM (GE Healthcare) 
Glass slides, 76 x 26 mm (Roth) 
Pestle 1.5 ml (Argos Technologies) 
Petri dish, bacterial, 90 mm (Greiner) 
PVDF membranes (Millipore) 
Reaction tubes, 0.5/1.5/2 ml (Eppendorf) 
Tissue culture flasks, 12.5/25 cm2 (Falcon) 
 
C.6 Antibodies 
 
Alpha tubulin, from rabbit (abcam) 
Anti-rabbit IgG, HRP-linked, from donkey (GE Healthcare) 
Anti-rabbit IgG, TexasRed-labelled, from sheep (abcam) 
Cardiac troponin I, from rabbit (abcam) 
 
C.7 Primers 
 
cAct, Mm_Actc1_1_SG (QIAGEN) 
cTropT2, Mm_Tnn2_1_SG (QIAGEN) 
Eef2, Mm_Eef2_2_SG (QIAGEN) 
Gapdh, Mm_Gapdh_3_SG (QIAGEN) 
Gata4, Mm_Gata4_1_SG (QIAGEN) 
Hcn4, Mm_Hcn4_2_SG (QIAGEN) 
Myh7, Mm_Myh7_2_SG (QIAGEN) 
Nanog, Mm_Nanog_1_SG (QIAGEN) 
Oct-3/4, Mm_Pou5f1_1_SG (QIAGEN) 
Sox2, Mm_Sox2_1_SG (QIAGEN) 
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C.8 Kit systems 
 
Alkaline Phosphatase Kit (SIGMA Aldrich) 
Click-iT EdU Flow Cytometry Assay Kit (Invitrogen) 
Click-iT EdU Imaging Kit (Invitrogen) 
FITC Active Caspase-3 Apoptosis Kit (BD Pharmingen) 
High Capacity RNA-to-cDNA Kit (Applied Biosystems) 
MasterPure RNA Purification Kit (Epicentre) 
 
C.9 Devices 
 
Autoclave, Autoklav EL (Tuttnauer) 
CCD microscope camera, JAI M300 (Stemmer Imaging) 
Centrifuge, Heraeus Fresco21 (Thermo Fisher Scientific) 
Centrifuge, Rotina 380 R (Hettich) 
Developer, Curix60 (AGFA) 
Dosimeter, SN4 (PTW Freiburg) 
Electrical cell counter, CASY TT Cell Counter (Schaerfe System) 
Flow cytometer, BD FACSCANTO II (BD) 
Fluorescence microscope, BX61 (Olympus) 
Freezing container, Cryo 1°C (NALGENE) 
Incubator (Binder) 
Light microscope (Leica) 
Liquid nitrogen container, Locator 8 Plus (Thermolyne) 
Multipipette tray (VWR) 
Sterile working bench, Herasafe HSP12 (Heraeus) 
Ultrasound sonicator, Bioruptor TM Ucd-200 (Diagenode) 
Water bath, ISOTEMP 215 (Fisher Scientific) 
X-ray tube, Isovolt DS1 (Seifert) 
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C.10 Software 
 
FACSDiva 6.0 (BD) 
Isis 5.0 (Metasystems) 
mFISH (Metasystems) 
OriginPro 8G (OriginLab) 
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